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Abstract
Can an epilepsy nurse specialist-led self-management
intervention reduce attendance at emergency departments
and promote well-being for people with severe epilepsy?
A non-randomised trial with a nested qualitative phase
L Ridsdale,1* P McCrone,1 M Morgan,1 L Goldstein,1
P Seed2 and A Noble1
1Institute of Psychiatry, King's College London, London, UK
2Division for Women's Health, King's College London, London, UK
*Corresponding author leone.ridsdale@kcl.ac.uk
Objectives: To (1) describe the characteristics and service use of people with established epilepsy (PWE)
who attend the emergency department (ED); (2) evaluate the economic impact of PWE who attend the ED;
(3) determine the effectiveness and cost-effectiveness of an epilepsy nurse specialist (ENS)-led
self-management intervention plus treatment as usual (TAU) compared with TAU alone in reducing ED use
and promoting well-being; (4) describe patients' views of the intervention; and (5) explore their reasons for
attending the ED.
Design: Non-randomised trial with nested qualitative study.
Setting: The EDs of three inner London hospitals. The EDs each offer similar services and support a similar
local population, which made a comparison of patient outcomes reasonable.
Participants: Adults diagnosed with epilepsy for ≥ 1 year were prospectively identiﬁed from the EDs by
presenting symptom/discharge diagnosis. We recruited 85 of 315 patients with 44 forming the
intervention group and 41 the comparison group.
Intervention: Intervention participants were offered two one-to-one outpatient sessions delivered by an
ENS who aimed to optimise self-management skills and knowledge of appropriate emergency service use.
The ﬁrst session lasted for 45–60 minutes and the second for 30 minutes.
Main outcome measures: The primary outcome was the number of ED visits that participants reported
making over the 6 months preceding the 12-month follow-up. Secondary outcomes were visits reported at
the 6-month follow-up and scores on psychosocial measures.
Results: In the year preceding recruitment, the 85 participants together made 270 ED visits. The frequency
of their visits was positively skewed, with 61% having attended multiple times. The mean number of visits
per participant was 3.1 [standard deviation (SD) 3.6] and the median was two (interquartile range 1–4).
Mean patient service cost was £2355 (SD £2455). Compared with ﬁndings in the general epilepsy
population, participants experienced more seizures and had greater anxiety, lower epilepsy knowledge and
greater perceived stigma. Their outpatient care was, however, consistent with National Institute for Health
and Clinical Excellence recommendations. In total, 81% of participants were retained at the 6- and
12-month follow-ups, and 80% of participants offered the intervention attended. Using intention-to-treat
analyses, including those adjusted for baseline differences, we found no signiﬁcant effect of the
intervention on ED use at the 6-month follow-up [adjusted incidence rate ratio (IRR) 1.75, 95% conﬁdence
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interval (CI) 0.93 to 3.28] or the 12-month follow-up (adjusted IRR 1.92, 95% CI 0.68 to 5.41), nor on any
psychosocial outcomes. Because they spent less time as inpatients, however, the average service cost of
intervention participants over follow-up was less than that of TAU participants (adjusted difference £558,
95% CI –£2409 to £648). Lower conﬁdence in managing epilepsy and more felt stigma at baseline best
predicted more ED visits over follow-up. Interviews revealed that patients generally attended because they
had no family, friend or colleague nearby who had the conﬁdence to manage a seizure. Most participants
receiving the intervention valued it, including being given information on epilepsy and an opportunity to
talk about their feelings. Those reporting most ED use at baseline perceived the most beneﬁt.
Conclusions: At baseline, > 60% of participants who had attended an ED in the previous year had
reattended in the same year. In total, 50% of their health service costs were accounted for by ED use and
admissions. Low conﬁdence in their ability to manage their epilepsy and a greater sense of stigma
predicted frequent attendance. The intervention did not lead to a reduction in ED use but did not cost
more, partly because those receiving the intervention had shorter average hospital stays. The most
common reason reported by PWE for attending an ED was the lack of someone nearby with sufﬁcient
experience of managing a seizure. Those who attended an ED frequently and received the intervention
were more likely to report that the intervention helped them. Our ﬁndings on predictors of ED use clarify
what causes ED use and suggest that future interventions might focus more on patients' perceptions of
stigma and on their conﬁdence in managing epilepsy. If addressed, ED visits might be reduced and
efﬁciency savings generated.
Trial registration: Current Controlled Trials ISRCTN06469947.
Funding: This project was funded by the NIHR Health Services and Delivery Research programme and will
be published in full in Health Services and Delivery Research; Vol. 1, No. 9. See the HSDR programme
website for further project information.
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Scientiﬁc summary
Introduction
Epilepsy is the most common serious neurological condition, with 0.6–1.0% of adults being affected at
any point in time. The seizures of over one-third of people with epilepsy (PWE) remain uncontrolled with
available treatments. As well as facing restrictions in activity and being at high risk of psychological distress
and perceived stigma, poor epilepsy control is associated with unnecessary hospital admissions, which NHS
policy aims to prevent. Epilepsy ranks highest of all chronic neurological conditions for emergency
readmission within a year.
One UK study found that 18% of people with established epilepsy had attended an emergency
department (ED) and 9% had been admitted to hospital for epilepsy in the previous year. A different study
found that 13% of PWE had attended an ED for epilepsy, with a mean number of visits of 0.3. There is a
gap in the evidence with regard to the frequency of ED use by PWE. If some people do attend EDs more
frequently it is also not clear what their characteristics are, whether some characteristics predict more or
less ED use and whether ED use was appropriate or preventable and, if so, by what means.
Epilepsy is costly. In the EU, the total cost of epilepsy was £15.5B in 2004. Six out of seven admissions for
epilepsy are on an emergency basis. Accordingly, some studies have found that the largest element of
health-care cost is associated with hospitalisation. However, there is a gap in the evidence with regard to
the actual costs of ED use by PWE, particularly in deprived areas where use is likely to be high. Western
economies are undergoing a period of recession, leading to restrictions in public spending. This means
that information on the costs of emergency visits by PWE is important for health service planners as they
scrutinise expenditure to reduce waste and optimise resource use.
The 2012 UK National Audit of Seizure Management in Hospitals (NASH) found that only a minority of
PWE who had attended an ED received a basic neurological examination, that advice was not typically
given to patients or carers on seizure management and that patients were not referred at the time for
assessment by the neurology team, or for follow-up by a relevant specialist. This suggests that there has
been little change in the service since a survey of usual ED care for PWE was carried out in the 1990s.
The needs of patients and the skills of care providers require careful matching, with the addition of an
overarching strategy. There is evidence from a US study that a nurse-led self-management intervention can
help patients manage their epilepsy and reduce hospital admissions. In this context we aimed to provide:
1. a description of people attending the ED for epilepsy, their use of the ED and their psychological state,
knowledge of epilepsy, perception of stigma, quality of life (QoL) and needs
2. an economic evaluation of people attending the ED for epilepsy to determine the cost both for PWE
and for society
3. quantitative evidence from a comparison of two groups, one receiving treatment as usual (TAU) and
the other receiving TAU and an epilepsy nurse specialist (ENS)-led self-management intervention
4. qualitative evidence of PWE's experiences of emergency services and the way in which services meet/do
not meet their needs, and their explanations of the process and rationale for attendance
5. qualitative evidence from a group receiving the ENS-led self-management intervention
6. an economic evaluation of the cost-effectiveness of services both for an ENS-led self-management
intervention and comparison groups before and after the nurse-led self-management intervention.
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Methods
Design
To achieve the aims we carried out a non-randomised trial, with a nested qualitative study, with PWE
recruited from EDs. The trial compared the effect of an ENS-led self-management intervention plus TAU
with the effect of TAU alone on subsequent ED use and psychosocial outcomes.
Setting
Patients attending the EDs of three inner London hospitals for epilepsy [King's College Hospital (KCH),
St. Thomas' Hospital (STH) and University Hospital Lewisham (UHL)] were prospectively (from May 2009
to March 2011) recruited. These similar EDs serve residents in the London boroughs of Southwark,
Lambeth and Lewisham respectively. Each borough has high levels of social deprivation and ethnic
diversity, comparable rates of emergency epilepsy admissions and a worse level of epilepsy control than
the national average.
Participants
Inclusion criteria were age ≥ 18 years, epilepsy diagnosed for ≥ 1 year and, to maximise the similarity of
patients composing the treatment groups, residing in Lambeth, Southwark or Lewisham. Exclusion criteria
were the inability to independently complete questionnaires, serious comorbidity, having seen an ENS in
the previous year or having been referred to neurology for outpatient care by the ED.
Interventions
Those recruited from STH and UHL formed the TAU comparison group, whereas those recruited from KCH
were each offered two one-to-one intervention sessions delivered on an outpatient basis at KCH by either
one of the two ENSs based at the hospital. The intervention aimed to optimise patients' self-management
skills and knowledge of appropriate emergency services use. The ﬁrst session lasted for 45–60 minutes
and took place 4 weeks following recruitment. The second session lasted for 30 minutes and took place
24 weeks later.
Outcome measures
Each participant was followed up for 12 months. Using validated questionnaires, participants were
assessed on recruitment (assessment 1), at 6 months (assessment 2) and at 12 months (assessment 3).
Questionnaires assessed their use of different health services (including the ED) for epilepsy (modiﬁed
Client Services Receipt Inventory, CSRI), seizures, health-related QoL (10-item Quality of Life in Epilepsy
Inventory, QOLIE-10), medication skills (medication subscale of the Epilepsy Self-Management Scale),
psychological distress (Hospital and Anxiety Depression Scale, HADS), felt stigma (Jacoby Stigma of Epilepsy
Scale), epilepsy knowledge (Epilepsy Knowledge Proﬁle – General, EKP-G), conﬁdence in managing
epilepsy (Epilepsy Mastery Scale), satisfaction with information received about medicines [Satisfaction with
Information about Medicines Scale (SIMS)] and, for the calculation of quality-adjusted-life years (QALYs),
health status (European Quality of Life-5 Dimensions, EQ-5D)
The primary outcome measure was the number of epilepsy-related ED visits that participants reported
having made at assessment 3 over the preceding 6 months. Secondary measures were the number of ED
visits that participants reported having made at assessment 2 over the preceding 6 months and scores on
the psychosocial questionnaires at assessments 2 and 3.
To obtain qualitative evidence on patients' reasons for attendance and their views of the intervention, the ﬁrst
24 participants completing the ﬁnal questionnaire were invited to take part in semistructured interviews.
Analysis
To evaluate the characteristics and needs of PWE attending the ED and their pattern of ED use (aim 1),
participants' responses to the questionnaires at the baseline assessment, which took place before
allocation to the different treatment groups, are described and compared with previous ﬁndings from the
SCIENTIFIC SUMMARY
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wider epilepsy population. The cost of the group's service use reported on the baseline CSRI for the year
before recruitment (aim 2) was calculated using national unit costs.
To compare the outcomes of the two treatment groups (aim 3), negative binomial regression examined
whether treatment allocation predicted ED visits made over follow-up. To account for imbalances between
the groups in baseline characteristics, baseline predictors of subsequent ED visits were identiﬁed and
adjusted for. Analyses were performed using an intention-to-treat approach with double-sided
signiﬁcance tests.
The cost-effectiveness of the intervention (aim 6) was determined by ﬁrst comparing the cost of the service
use reported by those in the two treatment groups following recruitment, after adjusting for baseline
costs. The National Institute for Health and Care Excellence (NICE) recommends integrating the level
of global health improvement perceived by patients from the different treatment groups into
cost-effectiveness analyses. As such, the service use costs for each of the groups were combined with
respective QALY gains.
Audio-recorded interviews from the qualitative study were transcribed verbatim and thematically
analysed (aim 5).
Results
In total, 85 of 315 eligible patients agreed to participate. Forty-four were recruited from KCH and formed
the intervention group and 41 were recruited from STH and UHL and formed the comparison group.
Participants' and non-participants' characteristics were similar. The follow-up rate at 6 and 12 months was
81%, and 35 (80%) participants offered the intervention attended.
Compared with the wider epilepsy population, participants' scores on the baseline measures indicated that
attendees experienced more seizures, had greater levels of anxiety, had lower epilepsy knowledge and
experienced greater perceived epilepsy-related stigma. Most of the participants' epilepsy outpatient care
was, however, consistent with standard criteria for quality.
In the 12 months preceding recruitment, the 85 participants had together made a total of 270
epilepsy-related ED visits [mean 3.1, standard deviation (SD) 3.6; median 2, interquartile range (IQR) 1–4].
The frequency of their visits was positively skewed. Over 60% were found to have made multiple visits to
the ED in the same year. Thirty-three (39%) had attended only once, 21 (25%) on two occasions and
31 (36%) on three or more occasions. The last group accounted for 72% of all visits and reported the
worst quality of life. Approximately one-quarter of participants had spent time as an inpatient, for which
the mean time in hospital was 5 days and the median 3 days. A high number of participants had also
spent time in an ED short-stay ward (‘clinical decision unit’).
The service costs for patients in the year before recruitment were skewed. The mean cost per patient was
£2355 (SD £2455). Inpatient stays and time spent in ED clinical decision units accounted for most (43%)
of the costs.
The outcome analyses found no signiﬁcant effect of the intervention compared with TAU alone on ED use
at either assessment 2 [adjusted incidence rate ratio (IRR) 1.75, 95% conﬁdence interval (CI) 0.93 to 3.28]
or assessment 3 (adjusted IRR 1.92, 95% CI 0.68 to 5.41) or on the measures of patient well-being.
Baseline variables were identiﬁed as predictive of a greater number of ED visits following recruitment, and
they were adjusted for. They were, in descending order of importance, lower conﬁdence in managing
epilepsy (less mastery), higher number of prescribed antiepileptic drugs (AEDs), more felt stigma, higher
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number of baseline ED visits, greater seizure frequency and higher levels of depression and anxiety.
In multivariate analyses, felt stigma and mastery remained signiﬁcantly predictive.
The cost-effectiveness results showed that over the entire follow-up period the average service cost for
intervention group participants was lower than that for TAU participants (adjusted difference £558,
95% CI –£2409 to £648). This was accounted for by the intervention participants having spent less time as
inpatients. The improvement in global health status reported by intervention participants (0.786 QALYs)
was, however, less than that reported by the comparison group (0.807 QALYs). Therefore, according to
NICE criteria, TAU was marginally more cost-effective.
Of the trial participants invited to interview, 19 (79%) agreed. Analysis of patients' reasons for attending
the ED for epilepsy revealed that seizures alone were not the main reason; knowledge, experience and
conﬁdence of those nearby of what to do, as well as seizure context, were also important. The fear of
sudden death held by the patient and others was also a trigger for ED use.
When asked about the intervention, most receiving it valued the additional support. Those who reported
at baseline having used an ED the most perceived the most beneﬁt. Participants said that the intervention
redressed limitations in their usual care, such as providing information about managing their epilepsy and
providing an opportunity to talk about their feelings. Beneﬁts that participants reported included improved
emotional well-being, conﬁdence in managing seizures and medication adherence.
Discussion
This study revealed the economic costs associated with visits to EDs by PWE and showed that PWE who
attend EDs frequently have complex needs. It provided needed information on the rate of return to EDs by
PWE and found that > 60% of PWE who attend an ED reattend in the same year. This rate of return is
higher than that reported for both the general ED population and for those with other chronic
elapsing conditions.
Developing interventions to reduce repeated ED use by PWE has been challenging as policy-makers have
lacked clear information about which factors inﬂuence visits to the ED by PWE. Evidence from our study
brings greater clarity to the issue. As well as conﬁrming that use of EDs by PWE is not satisfactorily
explained by epilepsy duration or severity alone, our study has provided evidence on the independent,
long-term predictive effects of other key variables on subsequent ED use. In multivariate analyses, felt
stigma and conﬁdence managing epilepsy (mastery) were found to be the best predictors of repeated use.
This indicates that these factors should be targets for future interventions aiming to reduce ED use
by PWE.
The interviews with participants also indicated that seizures were not always the main reason for an ED
attendance. Instead, what was important from the patients' perspective was whether or not they had
a family member, friend or colleague nearby who had the necessary skills to manage a seizure.
At interview, participants who received the ENS-led self-management intervention reported it to be
acceptable. It was described by participants as improving on usual epilepsy care. Some reported beneﬁts in
emotional well-being, conﬁdence managing seizures and medication adherence – domains possibly
causally related to ED use. The level of beneﬁt perceived by participants was, however, not universal.
Those who reported at baseline having used EDs the most perceived the most beneﬁt. For participants
who had used an ED on only one occasion, the beneﬁt was more negligible.
In line with this, the quantitative outcome analyses found no signiﬁcant overall effect of treatment group
on ED use or on the epilepsy-speciﬁc measures of patient well-being. However, costs were reduced
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after the intervention. The average service cost for intervention participants was £558 less than that for
TAU participants, with intervention participants spending less time as inpatients over follow-up.
Although there was no signiﬁcant difference between the intervention and TAU groups on the
epilepsy-speciﬁc quality of life outcome measure, the TAU group did report more improvement in health
status over the follow-up period. According to NICE's formulae, the intervention did not therefore
prove cost-effective.
Our study makes an important contribution to a small body of research. However, the results should be
interpreted in light of its limitations. For example, we recruited from an urban, ethnically diverse
population with high social deprivation. Our results may therefore not generalise to rural, less deprived
populations. Treatment was also not randomised, which may have served to reduce the accuracy of our
treatment effect estimate. Finally, although usual for such studies, the acceptance rate for the trial was
low. One implication of this was that we recruited fewer participants than planned and so CIs are wide for
key estimates.
In conclusion, we have described the high cost and complex challenges faced by PWE who attend the ED
frequently. Two sessions with a nurse lasting for 90 minutes were valued by frequent ED users, but were
not associated with signiﬁcant changes using quantitative measures. From what we learned in our
qualitative work, it may be helpful for PWE who attend the ED to test workshops for their family and
friends to learn about seizure management. The low conﬁdence in self-management skills, perception of
stigma and death anxiety voiced by some interviewees may also require the development and testing of a
more intensive intervention. From the economic evidence, an intervention that improves patient outcomes
and reduces hospital use, which accounts for 43% of patient costs, would beneﬁt PWE and the
health service.
Study registration
This study is registered as ISRCTN06469947.
Funding
The National Institute for Health Research Health Services and Delivery Research programme.
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Chapter 1 Introduction
Introduction to epilepsy in the context of the NHS
The stated policy of the NHS is to empower and support people with long-term conditions to understand
their own needs and self-manage them.1 In UK surveys of people with epilepsy (PWE), there has been a
consistent demand for better provision of information.2–5 One survey of patients with poorly controlled
epilepsy found that one-third reported not being told what epilepsy was, > 90% wanted more information
about the disease and ∼ 75% felt that they had not been given enough information about the side effects
of antiepileptic drugs (AEDs). Over 60% wanted to talk to someone other than a consultant about
epilepsy.4 PWE (and their carers) frequently lack the conﬁdence, however, to seek out such information.6
To date, the NHS has not implemented a routine programme of education or rehabilitation for PWE.
The National Service Framework for Long-Term Conditions7 includes epilepsy as a long-term condition.
Most adults with epilepsy experience paroxysmal loss of consciousness, and between attacks they do not
have obvious signs such as weakness, rigidity or incoordination that might beneﬁt from physiotherapy.
Disability between attacks is likely to be cognitive, psychological and social and so is largely hidden.
Perhaps this is why rehabilitation and advice on self-care have not generally been given a high proﬁle in
research or in practice.
The National Institute for Health and Care Excellence (NICE) advocates self-management education for
adults with epilepsy, aiming to achieve improvement in seizure frequency, increase individuals'
understanding of epilepsy and adherence to medication, decrease fear of seizures and reduce hazardous
self-management strategies.8 A Cochrane review9 concluded that so far there is some evidence of beneﬁt
from self-management approaches, but there is insufﬁcient evidence of improvement in health. Further
research in this area has been recommended.10,11
Poor epilepsy control is associated with unnecessary hospital admissions,12 which NHS policy aims to
prevent.13 Self-management education is designed, amongst other things, to reduce this, and providing
information should receive high priority.8 Improving health-related quality of life (HRQoL) for people with
long-term conditions and ensuring that people feel supported to manage their conditions are NHS
outcome targets.13 In the UK, self-management programmes have been tested and adopted for other
chronic conditions [e.g. diabetes: Dose Adjustment for Normal Eating (DAFNE),14 Diabetes Education and
Self Management for Ongoing and Newly Diagnosed (DESMOND),15 X-PERT;16 arthritis17,18].
What is the epidemiology of epilepsy?
The World Health Organization and the International League Against Epilepsy (ILAE) reported that epilepsy
is the most common serious neurological condition, affecting approximately 50 million people
worldwide.19 With 0.6–1.0% of adults affected at any point in time,20–22 there are approximately 315,000
adults with epilepsy in England. The lifetime prevalence of seizures is 2–5%.23 Epilepsy attacks are
intermittent and their frequency and severity are variable. After diagnosis most people achieve control of
attacks – studies show that 50–70% of PWE have had no attacks in the previous year.24,25 Although these
people have a long-term condition, most are able to participate in their social setting and adjust to the
initial distress of a potentially stigmatising condition.26–28
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The impact of poor epilepsy control
On an individual level
The same studies found that 30–50% of PWE have had an epilepsy attack in the previous year and 40%
have two or more seizures per year.24,25 People with poorly controlled epilepsy face restrictions in activity,
such as driving, which in turn affects work and social participation. Indeed, epilepsy alone accounts for 1%
of all global disability, as measured by productive life-years lost.29 Poor epilepsy control is also associated
with higher rates of psychological distress, including anxiety and depression, and perceived stigma.30,31
On acute hospital service use
One study24 found that 18% of PWE had attended a hospital emergency department (ED) and 9% had
been admitted to hospital for epilepsy in the previous year. A different study32 found that 13% of PWE
attended an ED for epilepsy, with a mean number of visits of 0.3. Shohet et al.33 explored this issue using
data from the 2004 Quality and Outcomes Framework (QOF).34 The QOF operates as a means of linking
the income of English primary care general medical practices to care quality. As part of this, practices
annually report the percentage of PWE (aged ≥ 16 years) registered on AEDs who were seizure free in the
last 12 months. Shohet et al. found that poor epilepsy control measured according to the QOF34 was
strongly associated with higher levels of emergency epilepsy-related hospitalisations. For those PWE-related
emergency admissions, the mean number of admissions was 1.3. There is a gap in the evidence with
regard to the frequency of ED use by PWE. However, use of health-care services is often not evenly
distributed.35 Some people attend infrequently or not at all, whereas others use services frequently.
Moore et al.36 examined reattendance within a 12-month period to an inner London hospital ED amongst
the general ED population. Reattendance was unusual – only 24% reattended, most doing so on one
occasion only. In contrast, those with chronic conditions with episodic relapse reattend more frequently.
International evidence shows that up to 67% of patients with chronic obstructive pulmonary disease
(COPD)37 and 42% with asthma37 or diabetes38 reattend within a 12-month period.
The distribution of ED use is unknown in epilepsy. However, there is evidence that it is the most frequent
neurological reason for emergency readmission into hospital.39 If some people do attend EDs more
frequently, there is a gap in the evidence about what their characteristics are, whether this service use is
appropriate or preventable and, if so, by what means.
What is the association between poor epilepsy control,
deprivation and acute hospital service use?
There is a strong correlation between the prevalence of epilepsy and social deprivation.40 Using evidence
derived from the QOF, Ashworth et al.41 found that patients with epilepsy living in socially deprived areas
were less likely to have had seizure control in the previous year. Gladman et al.42 found examples of some
neurological conditions that were better managed in major cites, particularly those with specialist
rehabilitation services. The implication is that, for some conditions, specialist rehabilitation can and has
achieved better outcomes. However, despite the presence of specialist services in English cities, we know
of no evidence showing that better epilepsy control has been achieved. Neurologists see patients referred
for diagnosis. After diagnosis there has not been a strategic approach to systematically identify people in
the catchment area with recurrent seizures, for example by their attendance at EDs. Less than one-quarter
of epilepsy-related ED attendees are referred for follow-up,43 and patients with poorly controlled epilepsy
may not expect much or ask for follow-up. Majeed et al.44 found that there are a greater number of
hospital emergency admissions amongst those living in deprived areas in London. Reactive acute services
are not linked with rehabilitation services.
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What is the consequence of poor epilepsy control in terms of
NHS cost?
Epilepsy is costly. In the EU, the total cost of epilepsy was £15.5B in 2004,45 with the total cost per case
being £2000–11,500. The largest element of health-care cost has often been found to be
hospitalisations.32,46 Six out of seven admissions for epilepsy are on an emergency basis.47 Of all
neurological conditions, epilepsy is associated with the highest rate of emergency readmissions within the
same year.39 In 2008–9, there were 37,140 NHS hospital admissions for which epilepsy was the primary
diagnosis.12 The average episode cost was £1514,48 indicating a total annual inpatient cost of £56.2M.
There may also be significant indirect societal costs through lost/absent employment.49
The costs are likely to be distributed unevenly because of differences in deprivation.44 These costs are all
estimated from research and national data sets with no in-depth research in speciﬁc areas of low or high
service use. The health economic gain from any intervention may be greater when there are low epilepsy
QOF scores, with high non-planned epilepsy admissions. On the other hand, when indicators suggest that
epilepsy control is very poor, step-up care might need to be highly intensive. If the ratio of cost to beneﬁt
is low, new services may be deemed too expensive in the current economic climate.
There is a gap in the evidence with regard to the actual costs of ED use by PWE, particularly in deprived
areas where use is likely to be high. As NHS commissioning becomes increasingly decentralised, this
cost information will be important for commissioners. This will be weighed against the potential
cost-effectiveness of any proactive intervention that is designed to improve the self-management of PWE.
What evidence is there with regard to usual care provided for
people with epilepsy who attend the emergency department?
In England all PWE are expected to have a structured medical review of their epilepsy at least yearly by
either a generalist or a specialist.50 Evidence nationally is that 95% of adults on drug treatment have had
their epilepsy reviewed in primary care in the last 15 months.51 In contrast, there is no currently accepted
care for those with established epilepsy who have visited an ED. NICE guidelines for epilepsy,50 however,
indicate that, when seizures are not controlled or treatment fails, it is expected that a patient will be
referred to tertiary services for assessment. The 2012 UK-wide National Audit of Seizure Management in
Hospitals (NASH)52 showed that UK EDs initiated this for only one-third of PWE attending EDs.
The NASH also found that only a minority of PWE who had attended an ED had a basic neurological
examination and that advice was not typically given to patients or their carers on seizure management.
These ﬁndings suggest that there has been little change in care since a survey of usual ED care for PWE
was carried out in the late 1990s by Reuber et al.43 The NASH also found that there was great variability
between hospitals, and some consensus is emerging that ED attendance is a lost opportunity to identify
and help PWE who have poor control and self-management (Association of British Neurologists
Conference, 2012, personal communication).
The need to know
All people with long-term conditions may beneﬁt from some self-help education, especially when ﬁrst
diagnosed; however, this does not always occur. In a previous qualitative study of PWE53 one person said:
They didn’t give me hardly anything (information), just sort of said, please take these tablets.
Female, 56 years
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Another summarised the lack of information and support:
I was left high and dry.
Male, 59 years
In epilepsy the need is particularly great when the person's knowledge of epilepsy is low54 or when he or
she experiences a negative psychological response to the diagnostic label or subsequent life events. The
reaction to loss, whether it be to a disease with negative consequences or any other loss, has been
characterised as including a range of responses such as fear, denial, anger, bargaining and depression as
well as acceptance.55 Negative psychological reactions to the diagnostic label of epilepsy, such as denial,
may considerably limit an individual's ability to take on new information needed to manage his or her
condition. Initial and subsequent experiences of seizures, with unconsciousness and possible injury, may
trigger fear. This was described by people following other conditions involving a sudden loss of
consciousness, such as subarachnoid haemorrhage, who also fear recurrence.56,57 In this condition fear and
catastrophic thinking has been conceptualised as a post-traumatic stress syndrome.58 PWE, particularly
those from minority ethnic groups, experience more than an internal struggle. Cultural beliefs in evil spirits
may be associated with epilepsy, and this may have negative consequences for PWE and their quality of,
and opportunities in, life.59,60 When ethnic groups represent multiple small diverse minorities as they do in
the UK, their special needs may not be recognised, as has been described for other conditions.61
Our research group54 found that, after diagnosis by a neurologist, the median score for PWE using
Jarvie et al.'s62 epilepsy knowledge questionnaire was 43 out of a maximum of 55, with a wide range of
12–51. Not having general education qualiﬁcations [General Certiﬁcate of Secondary Education (GCSE)],
normally undertaken at 16 years in the UK, was associated with a lower knowledge of epilepsy (one-third
of the general population have no qualiﬁcations). Compared with those in the highest knowledge of
epilepsy quartile, those in the lowest quartile had a median score that was 12 points lower on the
knowledge of epilepsy scale (26 vs. 48).54 It is arguable that, after diagnosis, a course of learning should be
tailored to the educational level of the PWE, with duration inversely related to educational attainment.
In another study we found that people with long-term epilepsy (average 23 years) did not have a higher
median knowledge score (42.5) than those with newly diagnosed epilepsy.63 As with those with new
epilepsy, educational attainment was predictive of epilepsy knowledge. Speciﬁcally, those with no GCSEs
had lower epilepsy knowledge scores (median score 39) than those with GSCEs or a higher qualiﬁcation
(median score 43). Lower epilepsy knowledge scores were also found in older people (37 vs. 43 in younger
people), in those who left school earlier rather than later (40 vs. 43) and in those not belonging to an
epilepsy self-help group (42 vs. 45). Multiple regression analysis showed that these predictors had
independent effects and so the additive consequences of social disadvantage for knowledge of epilepsy
are considerable.
Some people are affected more by their epilepsy than others. Like people with so-called ‘brittle’ diabetes,
these people can have difﬁculties controlling their epilepsy. They may beneﬁt from step-up care and
advice, which might be called rehabilitation. The speciﬁc characteristics of those whose condition impacts
on them more, in terms of distress to themselves and their families, reduced social participation and
possibly inappropriate service use, need to be identiﬁed. The study investigators responded to a NHS call
for research on rehabilitation. The research was funded by the National Institute for Health Research (NIHR)
and allocated to a self-help research group. We have used the terminology of self-help generally here, but
the issue of speciﬁc needs that may require speciﬁc services will become clear in the results and will be
taken up in the discussion.
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What is self-management?
There is no universally agreed deﬁnition of self-management. The US Institute of Medicine proposed that
self-management is ‘the tasks that individuals must undertake to live with one or more chronic conditions.
These tasks include having the conﬁdence to deal with medical management, role management and
emotional management of their conditions’ (p. 57).64
Self-management can be enhanced by ‘self-management programmes’. ‘Self-management programmes’,
as deﬁned by the Department of Health, ‘are not simply about educating or instructing patients about
their condition. They are based on developing the conﬁdence and motivation of patients to use their own
skills and knowledge to take effective control over life with a chronic illness’.65 Self-management therefore
aims to enhance patients' self-efﬁcacy by helping to solve identiﬁed problems, with beneﬁts for patients'
clinical outcomes and quality of life (QoL) and reduced hospital utilisation.66
Epilepsy self-management can be conceptualised as a range of actions and skills that help PWE feel more
conﬁdent about making decisions about their epilepsy, acting to improve seizure control, their use of
medication and living with epilepsy.49 Good self-management therefore involves PWE working in
partnership with health-care professionals to decide the best treatment and care plan for their epilepsy and
to assist them in developing conﬁdence and problem-solving skills and strategies to manage the emotional
and physical challenges of epilepsy.49
What is rehabilitation?
A critical review has been undertaken of evidence from the UK to support the concept of developing a
rehabilitation strategy.6 A rehabilitation service is not simply physical therapy. Rather, it can comprise a
multidisciplinary team of people who work together towards common goals for each patient, involve and
educate the patient and his or her family, have relevant knowledge and skills and can resolve most of the
common problems faced by their patients. Here the rehabilitation process aims to maximise the
participation of the patient in his or her social setting and minimise distress experienced by the patient and
distress and stress experienced by the patient's family and carers.67 As epilepsy is common, it is important
to identify those who will beneﬁt more speciﬁcally from rehabilitation services.
How should needs be matched with services for people
with epilepsy?
Is it self-care or rehabilitation?
Individuals have described their experiences of epilepsy movingly.68–71 Once diagnosed with epilepsy,
people vary in their ability to manage their condition and participate fully in daily life. The needs of people
and the skills of care providers need matching,72 with the addition of an overarching strategy.73 Health
services can be conceptualised as promoting and providing for self-help and/or rehabilitation. This includes
prevention of death and disability by the comprehensive and systematic care of established disease. This is
sometimes more a vision than a reality; nevertheless, care models lie on a continuum, which attempts to
provide a theory about how services might match people's needs.
What is the current evidence on epilepsy self-management?
Two Cochrane reviews9,10 found only three self-management studies targeting adults with epilepsy.74–76
A fourth study77 was published later. Psychological interventions have also been reviewed.11 None of the
interventions was trialled in the UK. Helgeson et al.75 reported the 2-day Sepulveda Epilepsy Education
(SEE) programme for adults in the USA. The Modular Service Package Epilepsy (MOSES)74 was evaluated in
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Europe and offered over 2 days. Olley et al.'s76 psychoeducational therapy programme was run in Nigeria.
Pramuka et al.77 trialled six weekly sessions of a psychosocial self-management programme in the USA.
Differences in study methodology prevented a direct comparison of ﬁndings in a meta-analysis.18 Of the
four self-management approaches for adults, MOSES74 has been evaluated in the greatest number of
participants, across 22 epilepsy centres (mainly specialist epilepsy hospital units). Its evaluation was the
most robust, with beneﬁts in terms of improved knowledge about epilepsy, better seizure control and
coping, and greater tolerance of, and fewer reported, side effects of AEDs. MOSES was delivered on an
inpatient basis to groups of PWE by a pair of educational facilitators drawn from a medical/nursing and
psychosocial background. An inpatient hospital course might facilitate access for PWE who cannot predict
when they will have seizures, but would be costly to provide. In the current economic climate it is likely
that NHS interventions need to be developed on an outpatient basis. Courses or sessions might also be
targeted only at those PWE who have the greatest needs, in terms of poor epilepsy control and high
service use.
What is the current evidence of the impact of epilepsy nurse
specialist-led advice on self-management for people with
epilepsy in ambulatory care?
Bradley and Lindsay9 reviewed specialist education and advice for neurological conditions and identiﬁed
three previous trials of the impact of epilepsy nurses, two undertaken by our own group.54,63,78 These trials
were undertaken in areas that were not deprived. As most people achieved good seizure control, the trials
focused on outcomes such as satisfaction with information provided, psychological distress and knowledge
of epilepsy. In the trial of an epilepsy nurse specialist (ENS)-led self-management intervention for people
with chronic epilepsy, there was improved patient satisfaction with the information provided and reduced
depression scores in the group who had experienced no recent seizure.53,63,79 Again, it was PWE with lower
educational levels who were found to have the least knowledge of epilepsy.63 In the trial of patients with
newly diagnosed epilepsy, those who were in the lowest knowledge quartile at baseline improved their
knowledge of epilepsy following an ENS-led self-management intervention.63
A small US study with ‘hard’ outcomes
There is evidence from a US study80 that a nurse-led intervention can help patients manage their epilepsy
and reduce hospital admissions. Nurses led on helping patients who had been hospitalised for epilepsy to
manage their condition, and this was associated with a reduction in seizure-related readmission at 90 days
(0/23 patients in the intervention group and 3/19 in the control group). This was a small but interesting
trial. Results from some case series also suggest that nurse interventions may reduce ED visits and
admissions.81,82
An epilepsy nurse specialist-led self-management intervention
in an area of poor epilepsy control
From the evidence, the potential for demonstrating change in outcomes and cost-effectiveness from
ENS-led rehabilitation might be greater in the context of high levels of deprivation, poor epilepsy control
and less social participation. We planned to achieve this by carrying out a study with patients in three
London boroughs, namely Lambeth, Southwark and Lewisham. These boroughs are in the top 10% of
English authorities for deprivation.83 The mean level of practice-reported seizures in 2007 was lower (50%)
than the national average (60%) [Mark Ashworth, general practitioner (GP) and Clinical Senior Lecturer,
Department of Primary Care and Public Health Sciences, King's College London, 22 December 2011,
personal communication]. There are three hospitals in this area: one lies in the north of Lambeth and
Southwark, one in the south and one in Lewisham. One hospital had two ENSs who previously only saw
patients referred by neurologists and neurosurgeons. They co-ordinate a multidisciplinary team approach
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to managing problems experienced by patients. The other hospitals had no ENSs. A sample of patients
with poor epilepsy control could be identiﬁed by recruiting ED attendees for epilepsy at each hospital. In a
previous audit we found that one out of 60 attendances were for epilepsy, with 40% of patients being
admitted. The plan was for the nurses to offer clinic appointments following discharge for those PWE
attending the ED for epilepsy, and lead on providing advice and support. The other hospitals would
continue to provide usual medical care.
Aims
The aims of the study were to provide:
1. a description of people attending the ED for epilepsy, their use of the ED and their psychological state,
knowledge of epilepsy, perception of stigma, QoL and needs
2. an economic evaluation of people attending the ED for epilepsy to determine the cost both for PWE
and for society
3. quantitative evidence from a comparison of two groups, one receiving treatment as usual (TAU) and
the other receiving TAU and an ENS-led self-management intervention
4. qualitative evidence of PWE's experiences of emergency services, the way in which services meet/do not
meet their needs and their explanations of the process of, and rationale for, attendance
5. qualitative evidence from the group receiving the ENS-led self-management intervention
6. an economic evaluation of the cost-effectiveness of services both for an ENS-led self-management
intervention and comparison groups before and after the ENS-led intervention.
Justiﬁcation for use of mixed methods, staging and reporting
in three streams
We will describe the work in three major streams: the ﬁrst used quantitative methods, the second used
qualitative methods and the third used health economic methodology. We gave priority to identifying
those PWE with poor control and evaluating step-up care. There is some evidence that use of emergency
medical services may be a proxy for poor control. Currently, there is comparatively little evidence on the
characteristics of PWE who attend EDs, and no evidence from the PWE themselves about what the process
is. In the current climate of recession the Department of Health and hospital medical services have strong
drivers to identify the reasons why six out of seven epilepsy admissions are unplanned, to reduce these
admissions, and to provide evidence on what the costs of reactive and proactive services might be.
We therefore used mixed methods to describe not only the demographic, psychological and social
characteristics of PWE who use EDs but also their views of why and how they use EDs. We planned to
describe not only whether an ENS-led self-management intervention reduces the use of EDs but also
whether PWE regard the intervention as useful or as not useful and why.
To avoid the interviews contaminating the responses to the questionnaires, the qualitative component was
scheduled to be carried out after the return of the ﬁnal questionnaires, 1 year after recruitment of the
participants. This sequence has a methodological advantage in terms of the prevention of contamination.
We realise that the results of neither of the two enquiries about reasons for calling the ED and
participants' views of the intervention can inform the intervention retrospectively; however, the results can
be used to inform future interventions, which might as a consequence be designed differently.
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Chapter 2 Quantitative component
We recruited people with established epilepsy from the EDs of three inner London hospitals andconducted a non-randomised trial (ISRCTN06469947). Those recruited from two of the hospitals
formed a TAU cohort, whereas those attending the ED of the remaining hospital were offered the
outpatient ENS-led self-management intervention plus TAU. Participants in both cohorts were assessed on
recruitment (baseline) and then at 6 and 12 months following recruitment.
This chapter is split into two sections. In the ﬁrst section we present the results from the baseline
assessments, which occurred before any differences had occurred in the care given to the two cohorts.
Results from this assessment are used to describe the characteristics, needs and previous service use of
PWE attending EDs for epilepsy.
In the second section we describe the effects of the ENS-led self-management intervention by comparing
the psychosocial outcomes and subsequent ED use of the two cohorts, adjusting for differences between
them at baseline.
STUDY 1: THE CHARACTERISTICS OF PEOPLE WHO ATTEND
HOSPITALS FOR EPILEPSY
The information collected from the baseline assessments was used to answer four speciﬁc questions
concerning the characteristics, needs and previous service use of PWE attending EDs for epilepsy:
1. What is the pattern of use of EDs by PWE?
2. What are the characteristics of this population?
3. What standard of outpatient epilepsy care have they been receiving?
4. What factors are most associated with frequent ED visits (cross-sectional analysis)?
Methods
Recruitment
From May 2009 to March 2011 we prospectively recruited PWE attending the EDs of three London
hospitals because of their condition. The hospitals were King's College Hospital (KCH), St. Thomas'
Hospital (STH) and University Hospital Lewisham (UHL). These are inner London facilities with comparable
EDs. Each is consultant led and offers a 24-hour service with full resuscitation facilities. Together they serve
1 million residents in the surrounding London boroughs of Southwark, Lambeth and Lewisham.84 The
prevalence of epilepsy in adults in this population is 0.51%.85
Each of the boroughs has high levels of social deprivation and ethnic diversity, similar rates of emergency
epilepsy admissions and a level of epilepsy control that is worse than the national average.85,86 Epilepsy
control is deﬁned here as the percentage of PWE prescribed AEDs in the local population who were
seizure free in the previous 12 months as recorded by primary care doctors in the boroughs as part of
England's 2009–10 QOF.85 According to this measure, 68% of PWE in the three boroughs were seizure
free during the period of recruitment, whereas the national average was 74%.
Inclusion criteria
People with epilepsy may visit a hospital ED for a variety of reasons. These include for acute seizures,
status epilepticus and seizure-related accidents (e.g. head injuries, burns) and causes (e.g. rash from
anticonvulsants). To identify PWE visiting the ED with a wide range of presentations, we convened an
expert panel of two emergency medicine and two neurology consultants to identify those symptoms and
diagnoses by which the three EDs classiﬁed attendances that they considered potentially indicative of an
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epilepsy-related attendance. During the recruitment phase a research worker (AN) and a neurology
consultant (LR) reviewed for eligibility ED records of patients falling into these categories.
People with established epilepsy were invited to participate in our study as long as their attendance was
caused by their epilepsy and they were aged ≥ 18 years, had had epilepsy diagnosed for ≥ 1 year, could
independently complete questionnaires and had no life-threatening or serious comorbidity (e.g. psychosis).
For the purposes of the subsequent trial phase of the project, we also excluded those who had seen an
ENS in the previous year, those referred to neurology for an outpatient appointment by the ED and, to
maximise the comparability of patients in the two cohorts, those visiting the ED who did not reside within
the local boroughs of Southwark, Lambeth or Lewisham.
Invitation letters were sent to eligible PWE shortly following their discharge from the ED. The Joint South
London and Maudsley and the Institute of Psychiatry NHS Research Ethics Committee approved the study
(08/H0807/86). Written informed consent was obtained from all participants.
Assessment
On recruitment, during a face-to-face appointment with a researcher (AN), participants completed
validated generic and epilepsy-speciﬁc self-report questionnaires.62,87–92 These included measures of their
epilepsy-related ED visits and care over the previous 12 months, epilepsy-related QoL, seizure frequency,
medication management skills, psychological distress, felt stigma, conﬁdence in managing epilepsy
(i.e. mastery) and epilepsy knowledge. Table 1 details the speciﬁc measures used.
Information collected on participants' epilepsy was restricted to that which was recorded in their primary
and secondary care medical records. Deprivation levels were estimated by linking their postcodes to the
Index of Multiple Deprivation.93 As noted by previous studies,43,103,104 information on the seizures that led
to the participants' ED attendances was not consistently reported in their ED records and so we do not
present this information here.
The standard of epilepsy care reported to have been received by each of the participants in the 12 months
preceding recruitment was compared with the following three NICE criteria for good epilepsy care.8 The ﬁrst
concerns access to specialist services: ‘[i]f seizures are not controlled and/or there is diagnostic uncertainty or
treatment failure, individuals should be referred to tertiary services . . . for further assessment’ (p. 44). The
second relates to medical review: ‘[a]ll individuals with epilepsy should have a regular structured review . . .
this . . . should be carried out at least yearly by either a generalist or specialist, depending on how well the
epilepsy is controlled’ (p. 44). The third concerns prescribed AEDs: ‘individuals should be treated with a single
antiepileptic drug . . . wherever possible’ (p. 56). The Clinical Standards Advisory Group104 further recommends
that ‘Monotherapy should be the rule . . . in at least 50% of those with established or severe epilepsy’ (p. 44).
Statistical analysis
Representativeness
To examine how representative our sample was of the population from which it was recruited, the
characteristics of the sample were compared with those of the group with established epilepsy who
attended the EDs for epilepsy during the recruitment period but who were not recruited.
The recruited sample was also then compared solely with those people who were eligible but who
declined participation.
Information on the non-recruited patients' characteristics was limited to that available in their ED records,
as wider access to their medical records was not ethically permissible. We were able to compare the age,
gender proﬁle, deprivation status and ethnicity of participants in the groups, as well as the clinical urgency
of the ED presentation as measured by the triage category that each patient was assigned to on arrival
at the ED.105 To permit an examination of the recruited and non-recruited groups' epilepsy and care
generally, we also extracted information recorded by their primary care practices for the 2009–10 QOF.106
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As noted in the previous chapter, the QOF operates as a means of linking the income of primary care
practices to care quality. For epilepsy, participating practices annually report (1) the percentage of PWE
(aged ≥ 16 years) registered on AEDs who were seizure free in the last 12 months (indicator 8); (2) the
percentage of PWE on AEDs who had a medication review in the last 15 months (indicator 7); and (3) the
percentage of PWE on AEDs with a record of seizures in the last 15 months (indicator 6). There is
variability between practices on these criteria.41
Mann–Whitney, Kruskal–Wallis and chi-square tests were used to compare groups on the variables noted.
Because information in ED records is often incomplete, each analysis was restricted to those without
missing data. When missing data exceeded 5%, those with and without missing data were compared.
Pattern of emergency department use, attendees' characteristics and standard
of epilepsy care
Descriptive statistics described the level of ED use, the standard of epilepsy care and the characteristics of
the recruited patients. When data were not normally distributed, the median and interquartile range (IQR)
were used to describe central tendency.
Association between level of previous emergency department use and
baseline factors
Regression analyses were used to estimate relationships between the frequency of previous ED use
reported at baseline and the other baseline variables. Coding of the variables is described in Table 2.
Unadjusted regression models were ﬁrst run to determine the relationship between each of the baseline
measures and the level of ED use in the previous 12 months. Variables signiﬁcantly associated with ED use
were then simultaneously entered into multiple regression analysis to identify parsimonious predictors.
Overdispersion and exclusion of zero values in baseline ED visit data meant that zero-truncated negative
binomial regression (NBR) was the most appropriate regression technique.35 Relative ED use is described in
incidence rate ratios (IRRs), with corresponding 95% conﬁdence intervals (CIs). The likelihood ratio test
examined overdispersion and the Wald statistic provided the statistical signiﬁcance of variables.
All p-values are two-sided and alpha set at 5%. Analyses were performed using Stata 12 (StataCorp LP,
College Station, TX, USA), SPSS 17.0 (IBM, Armonk, NY, USA) and StatsDirect 2.7.8 (StatsDirect, Cheshire, UK).
Results
Participants
During the recruitment period, 943 people attended the EDs because of established epilepsy. Of these,
315 were eligible and 85 (27%) were recruited. We found no signiﬁcant difference in the acceptance rates
between ED sites.
Reasons for exclusion were not living within one of the local boroughs served by the hospital (n = 352,
56.1%), unable to independently complete questionnaires (n = 115, 18.3%), having a serious comorbidity
(n = 83, 13.2%), having consulted an ENS < 1 year previously (n = 43, 6.8%) or having been referred to
neurology by the ED (n = 35, 5.6%) (Figure 1).
For those recruited, the median age at which epilepsy was diagnosed was 19 years (IQR 13.0–32.5 years)
and the median time since diagnosis was 11 years (IQR 6–28 years). In total, 34% lived in areas with a
deprivation score in the most deprived quintile for England.84
The longstanding nature of the participants' diagnoses meant that their epilepsy tended to be described
in their wider medical records according to the ILAE's older 1989 system of classiﬁcation.94 Speciﬁcally,
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37 patients (43.5%) were recorded as having experienced both focal and generalised seizures, 37 (43.5%)
only generalised seizures and six (7.1%) only partial seizures; for ﬁve patients (5.9%) no seizure type
was recorded.
The recruited sample was representative of the population from which it was drawn (Table 3), with no
signiﬁcant differences being found between those who were recruited and those who were not recruited.
However, when compared solely with those who were eligible but who declined participation, a signiﬁcant
difference was that more white than non-white ED attendees agreed to participate (p < 0.03).
Pattern of use of emergency departments by people with epilepsy
In the 12 months before the baseline assessment, the 85 PWE recruited from the EDs had together made
270 ED visits for epilepsy. Frequency of ED use amongst these PWE showed a strong positive skew
(Figure 2). The median number of visits in the previous year was two (IQR 1–4, range 1–25), with 61% of
participants reporting reattendance within 12 months. Speciﬁcally, 33 (39%) participants attended only
once, 21 (25%) attended on two occasions and the remaining 31 (36%) attended on three or more
occasions. This last group accounted for 72% of all ED visits. The median number of visits made by this
subgroup was ﬁve (IQR 4–7).
Assessed for eligibility (n = 943)
Excluded (n = 858) 
Not meeting inclusion criteria (n = 628)
Declined to participate (n = 230)
Assigned to epilepsy nurse specialist-led self-
management intervention (+TAU) (n = 44) 
Lost to follow-up (n = 4) 
Assigned to treatment as usual comparison c (n = 41) 
Received allocated intervention (n = 41)
Did not receive allocated intervention (n = 0)
One session (n = 17)
Two sessions (n = 12)
Three sessions (n = 6)  
Did not attend appointments (n = 8)
Refused intervention (n = 1) 
Non-response (n = 2)
Patient too ill (n = 1)
Patient too busy (n = 1) 
Analysed in intention-to-treat analysis (n = 37) 
Excluded from analysis (n = 0)
Lost to follow-up (n = 12) 
Non-response (n = 9) 
Death (n = 1) 
Patient moved away (n = 2) 
Received allocated intervention (n = 35) 
Did not receive allocated intervention (n = 9) 
Analysed in intention-to-treat analysis (n = 32) 
Excluded from analysis (n = 0)
Assignment
Analysis
Primary follow-up
Treatment assignment (n = 85)
Enrolment
FIGURE 1 Flow diagram of participant recruitment, treatment allocation and retention.
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TABLE 2 Characteristics of participants and association with frequency of ED use
Factor
All participants (n = 85),
n (%)
ED use,
median (IQR)
Association with ED use,
IRR (95% CI)a
Age (years), mean (SD) 41.12 (16)
Youngest quartile (18–26 years) 23 (27.1) 2 (1–5) 1.00 (reference)
Second quartile (27–42 years) 21 (24.7) 2 (1–4) 1.29 (0.44 to 3.81)
Third quartile (43–51 years) 20 (23.5) 2 (2–5) 1.07 (0.43 to 2.66)
Oldest quartile (52–89 years) 21 (24.7) 1 (1–2.5) 0.42 (0.16 to 1.12)
Gender
Male 45 (52.9) 2 (1–4.5) 1.00 (reference)
Female 40 (47.10) 2 (1–4) 0.86 (0.39 to 1.89)
Ethnicity
White British 51 (60) 2 (1–4) 1.00 (reference)
Other 34 (40) 2 (1–5) 1.36 (0.59 to 3.10)
Social deprivation, median (IQR) 32.07 (24.31–37.66)
Least deprived quartile (13.97–24.38) 22 (25.9) 1 (1–2.25) 1.00 (reference)
Second quartile (24.39–32.07) 21 (24.7) 3 (1–6) 2.37 (0.54 to 10.36)
Third quartile (32.08–37.62) 21 (24.7) 2 (1–4) 1.12 (0.24 to 5.33)
Most deprived quartile (37.63–47.46) 21 (24.7) 2 (2–4.5) 1.26 (0.28 to 5.69)
Epilepsy type
Focal 49 (57.6) 2 (1–3.5) 1.00 (reference)
Generalised 17 (20.0) 2 (1–5) 1.59 (0.69 to 3.70)
Undeﬁned 19 (22.4) 2 (1–5) 2.21 (0.89 to 5.49)
Seizure type
Partial and generalised 37 (43.5) 2 (1–4) 1.00 (reference)
Generalised only 37 (43.5) 2 (1–4.5) 0.64 (0.27 to 1.53)
Partial only 6 (7.1) 2 (1–3.75) 0.54 (0.16 to 1.87)
Unknown 5 (5.9) 5 (1.5–7) 2.16 (0.84 to 5.54)
Seizures in last year, median (IQR) 6 (3–10) – 1.22 (1.08 to 1.37)
Medication management,
median (IQR)
36.0 (32.5–38.0)
Highest management
quartile (39–40)
24 (28.2) 2 (1–3) 1.00 (reference)
Second quartile (37–38) 24 (28.2) 1 (1–4.5) 1.97 (0.49 to 7.97)
Third quartile (34–36) 17 (20.0) 2 (1–2.75) 1.01 (0.41 to 2.49)
Lowest management quartile
(21–33)
20 (23.5) 3 (1–6.75) 2.58 (1.06 to 6.27)
Anxiety, median (IQR) 8 (5.5–12)
Not anxious 36 (42.4) 2 (1–2) 1.00 (reference)
Borderline 21 (24.7) 2 (1–5.5) 2.29 (1.16 to 4.51)
Caseness 28 (32.9) 3 (1–5.75) 3.67 (1.67 to 8.09)
continued
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FIGURE 2 Histogram of the number of participant-reported ED attendances in the previous 12 months.
The distribution shows a positive skew (+3.40). In total, 39% of participants attended an ED once only.
TABLE 2 Characteristics of participants and association with frequency of ED use (continued )
Factor
All participants (n = 85),
n (%)
ED use,
median (IQR)
Association with ED use,
IRR (95% CI)a
Depression, median (IQR) 5 (2–7)
Not depressed 66 (77.6) 2 (1–3) 1.00 (reference)
Borderline 11 (12.9) 4 (1–6) 2.45 (1.19 to 5.03)
Caseness 8 (9.4) 4 (2–13.25) 5.07 (2.03 to 12.63)
Felt stigma, median (IQR) 2 (0–3)
Least stigmatised quartile (0) 27 (31.8) 1 (1–2) 1.00 (reference)
Second quartile (1–2) 20 (23.5) 2 (1–2.75) 1.64 (0.67 to 4.02)
Third quartile (3) 18 (21.2) 2 (1–4) 1.82 (0.84 to 3.93)
Most stigmatised quartile (4–8) 20 (23.5) 5 (2–7.75) 5.88 (2.62 to 13.19)
Social knowledge, median (IQR) 15 (13–16)
Most knowledgeable quartile (17–20) 26 (30.6) 1 (1–3) 1.00 (reference)
Second quartile (16) 37 (43.5) 1 (1–2.5) 1.41 (0.26 to 7.63)
Third quartile (14–15) 13 (15.3) 2 (1–3) 1.07 (0.33 to 3.44)
Least knowledgeable quartile (8–13) 9 (10.6) 4 (1.75–6.25) 3.55 (1.04 to 12.17)
Medical knowledge, median (IQR) 26 (22–28)
Most knowledgeable quartile (29–32) 26 (30.6) 1 (1–2.5) 1.00 (reference)
Second quartile (27–28) 24 (28.2) 2.5 (1–5) 2.80 (0.98 to 8.03)
Third quartile (23–26) 18 (21.2) 2 (1–2.75) 2.46 (0.59 to 10.12)
Least knowledgeable quartile (15–22) 17 (20.0) 2 (1–5) 3.46 (1.21 to 9.88)
a Entries in bold indicate statistically signiﬁcant IRR (p < 0.05).
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Characteristics of people with epilepsy attending emergency departments
Seizures
All of the participants had experienced an epileptic seizure in the previous year. In total, 39 (46%)
of the participants had experienced from two to nine seizures and 36 (42%) participants had experienced
≥ 10 seizures in the previous 12 months (Table 2). The median seizure severity score for the
54 (64%) participants who had a seizure in the 4 weeks preceding the baseline assessment was
57.5 (IQR 43.1–72.5).
TABLE 3 Summary of demographic and clinical data of patients recruited and not recruited into the study
Factor
PWE attending
the ED who
consented to
participate
(n = 85)
(group A)
PWE attending
the ED who
were not
eligible to
participate
(n=628)
(group B)
PWE attending
the ED who
were eligible
but who
declined to
participate
(n=230)
(group C)
Difference
(95% CI)
group A vs.
group B
Difference
(95% CI)
group A vs.
group C
Age (years),
mean (SD)
41.1 (16) 40.9 (17) 38.8 (16) −0.27 (−4.11 to 3.57) −2.36 (−6.37 to 1.65)
Males, n (%) 45 (52.9) 349 (55.6) 140 (60.9) −0.03 (−0.14 to 0.08) −0.08 (−0.20 to 0.04)
Median triage
priority (IQR)a
(1 = see
immediately,
5 = non-urgent)
3 (3–3) 3 (3–3.75) 3 (3–3) 0 (0 to 0) 0 (0 to 0)
White ethnicity,
n (%)b
51 (60) 270 (55.1) 78 (45.6) −0.05 (−0.16 to 0.07) 0.14 (0.01 to 0.27)c
Median deprivation
score (IQR)a
(score closer
to 1 =more
deprivation)
32.1 (24.3–37.7) 29.5 (21.1–37.0) 32.7 (28.7–38.3) 2.3 (0.01 to 4.67) −1.8 (−3.92 to 0.31)
Median score QOF
indicator 8 (IQR)d
(higher =more
seizure free)
70.4 (61.1–78.2) 71.4 (62.2–78.8) 67.9 (56.4–77.8) −0.9 (−4.1 to 2.1) 2.5 (−1.1 to 6)
Median score QOF
indicator 7 (IQR)d
(higher = better
epilepsy care)
96.2 (93.3–100) 95.7 (93.5–100) 96.8 (94.6–100) 0 (0.0 to 0.7) 0 (−1 to 0)
Median score
QOF indicator
6 score (IQR)d
(higher = better
epilepsy care)
97.2 (94.1–100) 96.5 (93.3–100) 97.1 (94.1–100) 0 (0.0 to 1.1) 0 (−0.3 to 0.4)
SD, standard deviation.
a Complete triage and deprivation data were available for 95% of participants.
b Complete ethnicity data were available for 79.2% of participants. Those with missing ethnicity data were not signiﬁcantly
different from those with complete data in terms of age, sex, ED triage category or deprivation status.
c Statistically signiﬁcant difference (p < 0.05).
d Complete QOF data were available for 81.9% of participants. Those with missing QOF data were signiﬁcantly younger (mean
difference = −5.4 years, 95% CI −7.8 to −2.9 years) and resided in more deprived areas (median difference −2.69, 95% CI
−4.79 to −0.61) than those with complete data.
QOF indicator 6, percentage of PWE on AEDs with a record of seizures in the previous 15 months; QOF indicator 7, percentage of
PWE on AEDs who had a medication review in the previous 15 months; QOF indicator 8, percentage of PWE (aged ≥ 16 years)
registered with their practice on AEDs who were seizure free in the last 12 months.
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Quality of life
Epilepsy-speciﬁc QoL, as represented by the mean total 10-item Quality of Life in Epilepsy (QOLIE-10)
score, was 26.30 (SD 7.95). Higher scores on this measure indicate poorer QoL, and participants who
reported having visited an ED the most in the previous 12 months reported the worst QoL. The mean QoL
score was 28.30 (SD 8.7) for those PWE who had visited an ED on three or more occasions in the previous
12 months, 26.04 (SD 7.9) for those who had attended on two occasions and 24.57 (SD 6.9) for those
who had visited once only.
Psychological distress
In total, 29 participants (34%) had a ‘case’ level of anxiety and/or depression, 28 (33%) had a ‘case’ level
of anxiety and eight (9.4%) had a ‘case’ level of depression. Days since last seizure were not signiﬁcantly
associated with anxiety or depression score.
Felt stigma
In total, 58 participants (68.2%) reported feeling stigmatised because of their epilepsy.
Epilepsy knowledge
Expressed as the mean per cent of correct answers, which is standard for this measure, the sample's scores
on the different epilepsy knowledge scales were 70.7 (SD 10.8) for total score, 68.2 (SD 9.9) for social
knowledge and 73.4 (SD 11.6) for medical knowledge. As an example, 24 (28.2%) of the participants
stated incorrectly on the social knowledge scale that it was always necessary to call a doctor or ambulance
if a person with epilepsy has a seizure, even if it occurred without complications.
Characteristics of emergency department attendees compared with those
of the wider epilepsy population
Table 4 presents a comparison of the ED attendees and the wider epilepsy population on some of the key
variables. In descending order of effect, this provides some evidence that ED attendees have experienced
more seizures, perceive more epilepsy-related stigma, have recently experienced more anxiety and have a
lower knowledge of epilepsy and its management.
Standard of outpatient epilepsy care that attendees had been receiving
Access to tertiary epilepsy services
Most participants (n = 68, 80%) considered their main epilepsy carer to be a hospital doctor rather than a
primary care doctor. Forty-three (51%) were being seen in general neurology clinics, 23 (27%) in
speciﬁcally named ‘epilepsy clinics’ and two (2%) by neuropsychiatry or neurosurgery services.
Frequency of medical review
Nearly all participants (n = 82, 96%) had received a medical review of their epilepsy in the previous
12 months, with 60 (71%) reporting attendance at a hospital clinic and 72 (85%) reporting attendance in
primary care. The median number of outpatient appointments for epilepsy was four (IQR 2–9).
Number of antiepileptic drugs prescribed
In total, 44 participants (52%) were taking monotherapy and 38 (45%) were taking polytherapy
(median 2, IQR 2–2.25); three were not taking AEDs at all.
Factors associated with frequency of emergency department visits
Because the dependent variable ED use was overdispersed (mean 3.17 < variance 12.89), we adopted a
negative binomial model. With use of unadjusted regression analysis, we found that in descending order
of importance increased felt stigma, increased depression, increased anxiety, lower social and medical
epilepsy knowledge, reduced medication self-management skills and increased seizure frequency were
each signiﬁcantly associated with increased use of EDs by PWE (see Table 2).
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TABLE 4 Comparison of the characteristics of the group recruited from EDs and the characteristics of samples
drawn from the wider epilepsy population
Factor
ED participants
(n = 85)
Wider epilepsy
population Reference study details
Seizures in last year, n (%)
(n = 1630) Moran et al.25 Postal survey of adults
with active epilepsy identiﬁed through
80 primary care practices, geographically
distributed across the UK
No seizures 0 (0.0) 843 (51.7)
One seizure 10 (11.8) 129 (7.9)
Two to nine seizures 39 (45.9) 280 (17.2)
≥ 10 seizures 36 (42.4) 378 (23.2)
Epilepsy type, n (%)
(n = four studies) Forsgren et al.107 Review of epidemiology
of epilepsy type in European studies
Focal 49 (57.6) (33–65)
Generalised 17 (20.0) (17–60)
Undeﬁned 19 (22.4) (2–8)
Seizure type, n (%)
(n = four studies) Forsgren et al.107 Review of epidemiology
of epilepsy type in European studies
Partial and generalised 37 (43.5) (55–83)
Generalised only 37 (43.5) (6–32)
Partial only 6 (7.1) –
Unknown 5 (5.9) (8–20)
Anxiety, n (%)
(n = 1176) Thapar.108 Survey of 82 adults
(77 face-to-face, ﬁve postal) with active
epilepsy from a epilepsy clinic in
Glasgow, UK
Not anxious (0–7) 36 (42.4) 429 (36.5)
Borderline (8–10) 21 (24.7) 487 (41.4)
Caseness (≥ 11) 28 (32.9) 260 (22.1)
Depression, n (%)
(n = 1185) Thapar et al.109 Postal survey of adults
with active epilepsy from a random
selection of 82 primary care practices in
Greater Manchester, UK
Not anxious (0–7) 66 (77.6) 878 (74.1)
Borderline (8–10) 11 (12.9) 170 (14.3)
Caseness (≥ 11) 8 (9.4) 137 (11.6)
Felt stigma, n (%)
(n = 1571) Taylor et al.90 Postal survey of adults with
newly diagnosed epilepsy from UK
hospital outpatient clinics recruited for
SANAD trial comparing standard and
new AEDs
None (0) 27 (31.8) 729 (46.4)
Mild to moderate (1–6) 50 (58.8) 746 (47.5)
High (7–9) 8 (9.4) 96 (6.1)
Epilepsy knowledge, mean % correct
(n = ﬁve studies) No single population reference is
available. However, Elliot and Shneker110
identiﬁed and reviewed ﬁve previous
European studies using the measure in
the wider epilepsy population and
reported the arithmetic mean scores.
Three studies had recruited from hospital
clinics, two from primary care and one
from user support groups
Social knowledge scale 68.2 71.8
Medical knowledge scale 73.4 75.0
Total knowledge score 70.7 74.3
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Multiple regression was performed for ED visits using those baseline variables that proved signiﬁcant in the
unadjusted analyses. The likelihood ratio test for alpha conﬁrmed that the data were signiﬁcantly
overdispersed [χ2(1) = 21.68, p < 0.001]. The model predicting ED visits using the reduced list of variables
remained statistically signiﬁcant [χ2(9) = 81.03, p < 0.001]. Having a level of social epilepsy knowledge in
the lowest quartile (p < 0.005), a sense of stigma in the highest quartile (p < 0.005), increased seizure
frequency (p < 0.005) and less than optimal medication self-management (lowest quartile) (p < 0.05)
remained signiﬁcant in the adjusted model and predicted more frequent ED use.
Based on their respective IRRs, it was lack of social epilepsy-related knowledge (2.10, 95% CI 1.31 to
3.35) and greater perceived stigma (2.08, 95% CI 1.32 to 3.25) that were found to be most highly
associated with ED use. On average, those with a social knowledge score in the lowest quartile had visited
an ED in the previous year on two occasions more than those with more knowledge. Those with a felt
stigma score in the highest quartile had visited an ED on three occasions more than those with lower felt
stigma scores. Holding other variables constant, compared with those with better self-reported medication
management, ED use was increased by 65% in those in the lowest quartile (IRR 1.65, 95% CI 1.02 to
2.67), and ED use increased by 11% for each category on the ordinal seizure frequency scale compared
with the one below (IRR 1.11, 95% CI 1.04 to 1.19).
Summary
In total, 85 patients were recruited. The mean age of participants was 41 years and 53% were male.
A total of 61% of participants reported reattending an ED within 12 months. PWE reported a mean of
3.2 and a median of two ED attendances in the last year. The rate of ED reattendance by PWE exceeds
that of ED users in general and those with most chronic conditions. However, ED use was not
homogeneous amongst participants, with some attending more frequently.
Compared with the wider epilepsy population and in descending order of effect, our results indicate that
PWE attending the ED have experienced more seizures, perceive more epilepsy-related stigma, have
recently experienced more anxiety and have lower knowledge of epilepsy and its management.
In the previous 12 months, the epilepsy outpatient care of most patients was consistent with standard
criteria for quality.
Our cross-sectional analysis showed that, in descending order, lower epilepsy knowledge, higher perceived
stigma, poorer self-medication management and higher seizure frequency were associated with the
patient having made more ED visits.
STUDY 2: A COMPARISON OF THE GROUPS OF PEOPLE
RECEIVING USUAL CARE AND AN EPILEPSY NURSE SPECIALIST-LED
SELF-MANAGEMENT INTERVENTION, AND A COHORT STUDY
OF PREDICTORS OF SERVICE USE
In this section we test the hypothesis that, compared with TAU alone, an ENS-led self-management
intervention can reduce reattendance at the ED and improve well-being (ISRCTN06469947).
In the previous section we described how PWE were recruited from three similar inner London hospital EDs
and completed self-report questionnaires on their service use and psychosocial well-being. To evaluate the
effect of the ENS-led self-management intervention on well-being and subsequent ED use, participants
who had attended the ED of one of the hospitals, KCH, were offered the intervention plus TAU whereas
those attending the EDs of the two remaining hospitals, STH and UHL, were offered TAU alone.
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Participants in both groups were then reassessed 6 and 12 months later and the responses of the groups
and their care were compared to determine the effect of the intervention. The similarity of the EDs made
comparison of the patients' outcomes reasonable.
Methods
Treatment arms
The epilepsy nurse specialist-led self-management intervention
(plus treatment as usual) group
Those from KCH were offered two one-to-one intervention sessions delivered on an outpatient basis at the
hospital. The initial session was scheduled to last for 45–60 minutes and the second session for
30 minutes. The intervention was planned to be responsive to a patient's individual needs and so the
number of sessions completed was permitted to vary slightly.
The intervention was informed by the premise that PWE, as opposed to medical care providers, are
responsible for their day-to-day epilepsy management. As such, PWE need the knowledge, support and
skills to mitigate disability and improve outcome.111 Sessions were delivered by either one of the two ENSs
based at KCH. Carers accompanied patients when PWE requested this.
To guide the intervention's delivery and record the information given and actions taken by the ENS during
sessions, a comprehensive checklist was developed (see Appendix 2). The intervention started with the ENS
reviewing the patient's epilepsy and checking that the AED(s) and dose that the patient reported taking
was aligned with his or her prescription. The ENS identiﬁed any self-management problems that the
patient was having, and factors relevant to their resolution. The ENS developed personalised care plans
with the patient, helped the patient set goals (e.g. to socialise more, be comfortable talking about
epilepsy, be less fearful about seizures), evaluated progress, provided the patient with the opportunity to
ask questions and provided information.
Information provision formed a large component of the intervention. The information that could be
provided included the causes of epilepsy; seizure ﬁrst aid; the role and mechanism of action of AEDs; the
importance of adherence to their medication and of taking the same brand; prescription charges; what to
do if a dose is missed; potential seizure triggers; safety in the home; legal rights of, and beneﬁts available
for, PWE; and the contact details of support organisations. The ENS also informed patients about the
name of their seizures and syndrome and, having reviewed their existing medical records, the probable
cause of their epilepsy.
With regards to advice concerning seizure ﬁrst aid, the ENS informed the patient what should and should
not be done when a seizure occurs and, as a permanent record, provided the patient with an information
pamphlet developed by the Epilepsy Society on ﬁrst aid management of seizures.112 As per these
guidelines, participants were informed that, usually, when a person has an epileptic seizure, there is no
need to call an ambulance. Emergency medical care is recommended only when any of the following
apply: (1) it is the person's ﬁrst seizure; (2) the person has injured him- or herself badly; (3) the person has
trouble breathing after the seizure has stopped; (4) one seizure immediately follows another with no
recovery in between; (5) the seizure lasts for 2 minutes longer than is usual or the seizure lasts for
> 5 minutes and you do not know how long the person's seizures usually last for.
The ENS could make referrals through normal pathways to other services, tailored to the patient's
requirements (e.g. counselling, social services, emergency rescue medication clinic). Any advice given and
actions taken were communicated to the patient's primary care doctor. At appointments, participants had
direct access to either of two ‘expert patients’ in the waiting room who were trained by the UK's Epilepsy
Society, and were invited to join a service users group.
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Before the trial, for reasons of limited service capacity, the ENSs accepted only direct referrals from
neurologists and neurosurgeons. They ran clinics but, as for this study, did not independently prescribe
AEDs. At the time of the intervention, one nurse had 8 years' experience working as an ENS and the other
had 10 years' experience.
Treatment-as-usual comparison group
Following recruitment, no restrictions were placed on the services that TAU participants could access.
At the time of the study no ENS services were part of TAU at STH or UHL.
Baseline and outcome assessments
Following their baseline assessment (assessment 1), the results of which were described in the previous
section, participants were assessed again at 6 months (assessment 2) and 12 months (assessment 3)
post recruitment. As at baseline, measures included those of their epilepsy-related ED visits and care,
health-related QoL, seizure frequency, medication management skills, psychological distress, felt stigma,
conﬁdence in managing epilepsy (i.e. mastery) and epilepsy knowledge. Table 1 details the measures used
at each assessment.
As for assessment 1, the questionnaires at assessment 2 were completed during a face-to-face follow-up
appointment with AN, who was not blind to treatment allocation. However, assessment 3 was completed
by post. Questionnaires on care received, service use and seizure frequency referred to the previous
12 months at assessment 1 and the previous 6 months at assessments 2 and 3.
Sample size
Jacoby et al.32 found that 27% of PWE in the UK with uncontrolled epilepsy (more than one seizure a
month) make at least one ED visit per year. We considered that the intervention might reduce this to 7%
(rate ratio 0.26), partly by more effective self-management and partly by more frequent and appropriate
use of non-emergency services. Following Parmar and Machin's113 formulae, full data on 60 participants in
each treatment group would give 80% power to detect such a difference. We planned to recruit 160
subjects to allow for 25% loss to follow-up.
Statistical analysis
Treatment group equivalence and care received
Descriptive statistics describe the characteristics of those recruited into each of the treatment arms, those
retained at each follow-up assessment and the epilepsy care that patients received following recruitment.
Logistic regression tested for the signiﬁcance of differences between the groups. Odds ratios (ORs) and
95% CIs are presented.
Effect of intervention on emergency department use
Analyses were performed using an intention-to-treat approach. The primary outcome was the number of
ED visits that participants reported making over the previous 6 months at assessment 3. Secondary
measures were ED visits reported to have been made over the 6 months preceding assessment 2 and
psychosocial outcomes at assessments 2 and 3. A p-value of < 0.05 was considered signiﬁcant for
outcome analyses, with no adjustments made for multiple comparisons.
To examine the effect of the ENS-led self-management intervention on ED visits compared with TAU
alone, NBR was used to determine whether treatment allocation predicted ED visits made over follow-up.
Overdispersion of ED visits meant that NBR, with robust standard errors, was appropriate.35
Unadjusted NBR analyses were ﬁrst completed. However, to account for imbalances in baseline
characteristics between the treatment groups, which may have confounded the estimated association
between condition and subsequent ED use, we also completed adjusted NBR analyses. This involved ﬁrst
undertaking a process of model building, in which we examined the association between scores on each
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baseline measure and ED visits at assessments 2 and 3. Those covariates with a marginal statistical
association (p < 0.10) were then included in the applicable adjusted NBR analyses. The adjustments made
for each model are indicated in the table notes.
Estimates of treatment effect are presented in the form of IRRs with 95% CIs. IRRs < 1 represent a lower
ED visit rate in the intervention group relative to TAU, whereas IRRs > 1 indicate a higher ED visit rate in
the intervention group relative to TAU.
Effect of intervention on secondary outcome measures
For secondary outcomes, scores were treated as continuous, and linear regression, with robust standard
errors, tested for treatment effects. Results from unadjusted and adjusted analyses are presented, with
treatment effect estimates given in the form of unstandardised coefﬁcients. Positive coefﬁcients indicate an
increase in the score on the outcome variable associated with receiving the ENS-led self-management
intervention, whereas negative coefﬁcients indicate the opposite.
All analyses were performed using Stata 11.
Results
Participants
Recruitment and baseline condition equivalence
Of the 85 recruited PWE, 44 were recruited from KCH and formed the intervention group and 41 came
from STH and UHL and formed the comparison group. Figure 1 depicts their recruitment and retention.
At assessment 1 (baseline), participants in the two groups were broadly comparable (Table 5). The
comparison group did, however, report having experienced signiﬁcantly more seizures in the previous year
[median seizure number 10 (IQR 1.2–4.5) vs. 5.5 (IQR 1.0–3.0) in the intervention group]. The groups also
differed on the related seizure frequency indicator of the 2009–10 QOF measure.85
Retention at follow-up
In total, 69 participants (81%) were retained at assessments 2 and 3. Loss to follow-up was not equal
between the treatment arms and those lost differed from those retained in terms of baseline
characteristics. A total of 37 participants (90%) from the comparison group were retained compared with
32 intervention participants (73%). This further imbalanced the baseline characteristics of the two groups
(Table 6). As well as the intervention group still having had fewer seizures, it also now had fewer
participants who felt highly stigmatised by epilepsy at baseline. At the same time, however, there were
more in the intervention group who had a comorbid condition.
Reasons for loss are presented in Figure 1. Of note, one participant died of sudden unexplained death in
epilepsy. This patient was allocated to the intervention study arm but failed to attend any appointments
with the ENS.
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TABLE 5 Baseline characteristics of study participants according to treatment group and assessment
Baseline measure
Treatment groups at baseline, n (%)
OR (95% CI)Comparison (n = 41) Intervention (n = 44)
Age at baseline (years)
18–24 6 (14.6) 8 (18.2) 1.00 (reference)
25–34 8 (19.5) 12 (27.3) 1.55 (0.56 to 4.31)
35–45 7 (17.1) 7 (15.9) 0.92 (0.29 to 2.91)
46–53 12 (29.3) 8 (18.2) 0.54 (0.19 to 1.50)
54–89 8 (19.5) 9 (20.5) 1.06 (0.36 to 3.09)
Gender
Male 22 (53.7) 24 (54.5) 1.00 (reference)
Female 19 (46.3) 20 (45.5) 0.97 (0.41 to 2.28)
Ethnicity
Other 17 (41.5) 17 (38.6) 1.00 (reference)
White British 24 (58.5) 27 (61.4) 0.89 (0.37 to 2.13)
Years of formal education
10 (least educated) 2 (4.9) 1 (2.3) 1.00 (reference)
11 24 (58.5) 19 (43.2) 0.54 (0.23 to 1.28)
12 2 (4.9) 2 (4.5) 0.93 (0.12 to 7.00)
13–15.5 6 (14.6) 10 (22.7) 1.72 (0.56 to 5.28)
16–24 (most educated) 7 (17.1) 12 (27.3) 1.82 (0.63 to 5.24)
Deprivation score
13.97–22.70 (least deprived) 5 (12.2) 12 (27.3) 1.00 (reference)
23.36–28.98 9 (22.0) 8 (18.2) 0.79 (0.27 to 2.31)
29.75–33.46 7 (17.1) 10 (22.7) 1.43 (0.48 to 4.22)
33.56–38.31 11 (26.8) 7 (15.9) 0.52 (0.18 to 1.50)
38.76–47.46 (most deprived) 9 (22.0) 7 (15.9) 0.67 (0.22 to 2.02)
Comorbidity
None 23 (56.1) 20 (45.5) 1.00 (reference)
Psychiatric and/or medical 18 (43.9) 24 (54.5) 1.53 (0.65 to 3.63)
Years epilepsy diagnosed
2–4 5 (12.2) 10 (22.7) 1.00 (reference)
5–8 9 (22.0) 7 (15.9) 0.67 (0.22 to 2.02)
9–15 7 (17.1) 13 (29.5) 2.04 (0.72 to 5.80)
16–34 9 (22.0) 8 (18.2) 0.79 (0.27 to 2.31)
35–67 11 (26.8) 6 (13.6) 0.43 (0.14 to 1.31)
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TABLE 5 Baseline characteristics of study participants according to treatment group and assessment (continued )
Baseline measure
Treatment groups at baseline, n (%)
OR (95% CI)Comparison (n = 41) Intervention (n = 44)
ED visits last 12 months
1 15 (36.6) 18 (40.9) 1.00 (reference)
2 12 (29.3) 10 (22.7) 0.71 (0.27 to 1.90)
3–4 3 (7.3) 8 (18.2) 2.82 (0.69 to 11.55)
5–25 11 (26.8) 8 (18.2) 0.61 (0.22 to 1.71)
Seizures last 12 months
1–2 7 (17.1) 10 (22.7) 1.00 (reference)
3–5 6 (14.6) 12 (27.3) 2.19 (0.73 to 6.56)
6–9 6 (14.6) 8 (18.2) 1.30 (0.41 to 4.15)
≥ 10 22 (53.7) 14 (31.8) 0.40 (0.17 to 0.98)
Primary care QOF 8 score
0.00–56.4 (fewer seizure free) 6 (14.6) 11 (25.0) 1.00 (reference)
58.3–65.4 10 (24.4) 7 (15.9) 0.59 (0.20 to 1.73)
65.5–73.6 10 (24.4) 6 (13.6) 0.49 (0.16 to 1.51)
75.9–78.9 10 (24.4) 8 (18.2) 0.69 (0.24 to 1.97)
80.0–91.7 (more seizure free) 5 (12.2) 12 (27.3) 2.70 (0.85 to 8.56)
Seizure severity score
0–5 (least severe) 13 (32.5) 20 (45.5) 1.00 (reference)
7.5–50 10 (25) 6 (13.6) 0.47 (0.15 to 1.46)
52.5–67.5 9 (22.5) 8 (18.2) 0.77 (0.26 to 2.24)
70–90 (most severe) 8 (20) 10 (22.7) 1.18 (0.41 to 3.38)
Seizure onset
Generalised or unknown 19 (46.3) 17 (38.6) 1.00 (reference)
Focal 22 (53.7) 27 (61.4) 1.37 (0.58 to 3.27)
AEDS prescribed
0 1 (2.4) 2 (4.5) 1.00 (reference)
1 18 (43.9) 26 (59.1) 1.85 (0.78 to 4.39)
2 16 (39.0) 13 (29.5) 0.66 (0.27 to 1.62)
3–5 6 (14.6) 3 (6.8) 0.43 (0.10 to 1.85)
Depression score
0–1 (least symptoms) 11 (26.8) 2 (4.5) 1.00 (reference)
2–3 11 (26.8) 26 (59.1) 0.70 (0.26 to 1.93)
4–5 4 (9.8) 0 (0.0) 2.72 (0.77 to 9.56)
6–7 7 (17.1) 13 (29.5) 1.43 (0.48 to 4.22)
8–19 (most symptoms) 8 (19.5) 3 (16.8) 1.38 (0.49 to 3.88)
continued
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TABLE 5 Baseline characteristics of study participants according to treatment group and assessment (continued )
Baseline measure
Treatment groups at baseline, n (%)
OR (95% CI)Comparison (n = 41) Intervention (n = 44)
Anxiety score
0–4 (least symptoms) 7 (17.1) 7 (15.9) 1.00 (reference)
5–7 10 (24.4) 12 (27.3) 1.16 (0.44 to 3.10)
8–9 8 (19.5) 6 (13.6) 0.65 (0.20 to 2.09)
10–12 9 (22.0) 10 (22.7) 1.05 (0.37 to 2.92)
13–19 (most symptoms) 7 (17.1) 9 (20.5) 1.25 (0.42 to 3.76)
QoL score
13–18 (highest QoL) 9 (22.0) 7 (15.9) 1.00 (reference)
19–23 7 (17.1) 11 (25.0) 1.62 (0.56 to 4.71)
24–26 6 (14.6) 8 (18.2) 1.30 (0.41 to 4.14)
27–33 11 (26.8) 8 (18.2) 0.61 (0.22 to 1.71)
34–36 (lowest QoL) 8 (19.5) 10 (22.7) 1.21 (0.42 to 3.47)
Felt stigma score
0 (least stigma) 12 (29.3) 15 (34.1) 1.00 (reference)
1–2 9 (22.0) 10 (22.7) 1.05 (0.37 to 2.92)
3–4 8 (19.5) 13 (29.5) 1.73 (0.63 to 4.77)
5–9 (most stigma) 12 (29.3) 6 (13.6) 0.38 (0.13 to 1.15)
Medication management
13–39 (lowest skills) 5 (12.5) 11 (25.0) 1.00 (reference)
40–44 6 (15.0) 10 (22.7) 1.90 (0.65 to 5.54)
45–46 9 (22.5) 10 (22.7) 1.18 (0.44 to 3.16)
47–48 8 (20.0) 7 (15.9) 0.93 (0.32 to 2.72)
49–50 (highest skills) 12 (30.0) 6 (13.6) 0.48 (0.16 to 1.41)
Satisfaction with medication information
1–4 (least satisﬁed) 7 (17.5) 7 (16.3) 1.00 (reference)
5–7 8 (20.0) 10 (23.3) 1.21 (0.42 to 3.48)
8–9 6 (15.0) 9 (20.9) 1.50 (0.48 to 4.71)
10–11 8 (20.0) 10 (23.3) 1.21 (0.42 to 3.48)
12–17 (most satisﬁed) 11 (27.5) 7 (16.3) 0.51 (0.18 to 1.50)
Social knowledge
8–12 (lowest knowledge) 10 (24.4) 5 (11.4) 1.00 (reference)
13–14 13 (31.7) 13 (29.5) 0.90 (0.36 to 2.29)
15 9 (22.0) 13 (29.5) 1.49 (0.56 to 4.01)
16–20 (highest knowledge) 9 (22.0) 13 (29.5) 1.49 (0.56 to 4.01)
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TABLE 5 Baseline characteristics of study participants according to treatment group and assessment (continued )
Baseline measure
Treatment groups at baseline, n (%)
OR (95% CI)Comparison (n = 41) Intervention (n = 44)
Medical knowledge
15–21 (lowest knowledge) 11 (26.8) 7 (15.9) 1.00 (reference)
22–24 9 (22.0) 8 (18.2) 0.79 (0.27 to 2.31)
25–26 7 (17.1) 8 (18.2) 1.08 (0.35 to 3.32)
27–28 7 (17.1) 11 (25.0) 1.62 (0.56 to 4.71)
29–32 (highest knowledge) 7 (17.1) 10 (22.7) 1.43 (0.48 to 4.22)
Mastery
6–12 (lowest conﬁdence) 10 (24.4) 8 (18.2) 1.00 (reference)
13–14 8 (19.5) 11 (25.0) 1.38 (0.49 to 3.88)
15 5 (12.2) 8 (18.2) 1.60 (0.47 to 5.40)
16–17 8 (19.5) 10 (22.7) 1.21 (0.42 to 3.47)
18–21 (highest conﬁdence) 10 (24.4) 7 (15.9) 0.59 (0.20 to 1.73)
Primary care QOF 8 score, percentage of PWE (aged ≥ 16 years) prescribed AEDs in the local population who were seizure
free in the previous 12 months as recorded by primary care medical practices in England in 2009–10.
p < 0.10 shown in bold; logistic regression used.
TABLE 6 Baseline characteristics of study participants according to treatment group at follow-up assessment
Baseline
measure
Treatments groups at
assessment 2, n (%)
OR (95% CI)
Treatments groups at
assessment 3, n (%)
OR (95% CI)
Comparison
(n = 37)
Intervention
(n = 32)
Comparison
(n = 37)
Intervention
(n = 32)
Age at baseline (years)
18–24 5 (13.5) 5 (15.6) 1.00 (reference) 5 (13.5) 2 (6.3) 1.00 (reference)
25–34 8 (21.6) 8 (25.0) 1.21 (0.39 to 3.73) 7 (18.9) 9 (28.1) 1.68 (0.54 to 5.22)
35–45 7 (18.9) 5 (15.6) 0.79 (0.22 to 2.82) 7 (18.9) 6 (18.8) 0.99 (0.29 to 3.35)
46–53 9 (24.3) 6 (18.8) 0.72 (0.22 to 2.32) 12 (32.4) 6 (18.8) 0.48 (0.16 to 1.49)
54–89 8 (21.6) 8 (25.0) 1.21 (0.39 to 3.73) 6 (16.2) 9 (28.1) 2.02 (0.63 to 6.54)
Gender
Male 20 (54.1) 14 (43.8) 1.00 (reference) 20 (54.1) 13 (40.6) 1.00 (reference)
Female 17 (45.9) 18 (56.3) 1.51 (0.58 to 3.95) 17 (45.9) 19 (59.4) 1.72 (0.66 to 4.51)
Ethnicity
Other 17 (45.9) 10 (31.3) 1.00 (reference) 23 (62.2) 21 (65.6) 1.00 (reference)
White British 20 (54.1) 22 (68.8) 0.54 (0.20 to 1.45) 14 (37.8) 11 (34.4) 0.86 (0.32 to 2.33)
continued
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TABLE 6 Baseline characteristics of study participants according to treatment group at follow-up assessment
(continued )
Baseline
measure
Treatments groups at
assessment 2, n (%)
OR (95% CI)
Treatments groups at
assessment 3, n (%)
OR (95% CI)
Comparison
(n = 37)
Intervention
(n = 32)
Comparison
(n = 37)
Intervention
(n = 32)
Years of formal education
10
(least educated)
1 (2.7) 1 (3.1) 1.00 (reference) 2 (5.4) 1 (3.1) 1.00 (reference)
11 21 (56.8) 13 (40.6) 0.52 (0.20 to 1.37) 21 (56.8) 12 (37.5) 0.46 (0.17 to 1.21)
12 2 (5.4) 2 (6.3) 1.17 (0.15 to 8.92) 1 (2.7) 2 (6.3) 2.40 (0.20 to 28.28)
13–15.5 6 (16.2) 6 (18.8) 1.19 (0.34 to 4.18) 6 (16.2) 7 (21.9) 1.45 (0.43 to 4.90)
16–24
(most educated)
7 (18.9) 10 (31.3) 1.95 (0.64 to 5.97) 7 (18.9) 10 (31.3) 1.95 (0.64 to 5.97)
Deprivation score
13.97–22.70
(least deprived)
5 (13.5) 11 (34.4) 1.00 (reference) 4 (10.8) 10 (31.3) 1.00 (reference)
23.36–28.98 7 (18.9) 3 (9.4) 0.44 (0.10 to 1.90) 8 (21.6) 3 (9.4) 0.38 (0.09 to 1.57)
29.75–33.46 7 (18.9) 5 (15.6) 0.79 (0.22 to 2.82) 6 (16.2) 7 (21.9) 1.45 (0.43 to 4.90)
33.56–38.31 11 (297) 7 (21.9) 0.66 (0.22 to 1.99) 11 (29.7) 6 (18.8) 0.55 (0.17 to 1.71)
38.76–47.46
(most deprived)
7 (18.9) 6 (18.8) 0.99 (0.29 to 3.35) 8 (21.6) 6 (18.8) 0.84 (0.25 to 2.76)
Comorbidity
None 20 (54.1) 12 (37.5) 1.00 (reference) 22 (59.5) 11 (34.4) 1.00 (reference)
Psychiatric
and/or medical
17 (45.9) 20 (62.5) 1.96 (0.74 to 5.18) 15 (40.5) 21 (65.6) 2.80 (1.04 to 7.52)
Years epilepsy diagnosed
2–4 4 (10.8) 6 (18.8) 1.00 (reference) 5 (13.5) 7 (21.9) 1.00 (reference)
5–8 9 (24.3) 6 (18.8) 0.72 (0.22 to 2.32) 7 (18.9) 4 (12.5) 0.61 (0.16 to 2.34)
9–15 7 (18.9) 9 (28.1) 1.68 (0.54 to 5.22) 7 (18.9) 9 (28.1) 1.68 (0.54 to 5.22)
16–34 7 (18.9) 6 (18.8) 0.99 (0.29 to 3.35) 9 (24.3) 7 (21.9) 0.87 (0.28 to 2.71)
35–67 10 (27.0) 5 (15.6) 0.50 (0.15 to 1.67) 9 (24.3) 5 (15.6) 0.58 (0.17 to 1.96)
ED visits last 12 months
1 14 (37.8) 15 (46.9) 1.00 (reference) 14 (37.8) 14 (43.8) 1.00 (reference)
2 12 (32.4) 8 (25.0) 0.69 (0.24 to 2.01) 11 (29.7) 8 (25.0) 0.79 (0.27 to 2.31)
3–4 3 (8.1) 6 (18.8) 2.62 (0.59 to 11.58) 2 (5.4) 6 (18.8) 4.04 (0.74 to 21.91)
5–25 8 (21.6) 3 (9.4) 0.38 (0.09 to 1.57) 10 (27.0) 4 (12.5) 0.39 (0.11 to 1.39)
Seizures last 12 months
1–2 7 (18.9) 7 (21.9) 1.00 (reference) 5 (13.5) 7 (21.9) 1.00 (reference)
3–5 5 (13.5) 8 (25.0) 2.13 (0.61 to 7.41) 6 (16.2) 8 (25.0) 1.72 (0.52 to 5.68)
6–9 5 (13.5) 6 (18.8) 1.48 (0.40 to 5.44) 5 (13.5) 7 (21.9) 1.79 (0.50 to 6.38)
≥ 10 20 (54.1) 11 (34.4) 0.45 (0.17 to 1.19) 21 (56.8) 10 (31.3) 0.35 (0.13 to 0.94)
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TABLE 6 Baseline characteristics of study participants according to treatment group at follow-up assessment
(continued )
Baseline
measure
Treatments groups at
assessment 2, n (%)
OR (95% CI)
Treatments groups at
assessment 3, n (%)
OR (95% CI)
Comparison
(n = 37)
Intervention
(n = 32)
Comparison
(n = 37)
Intervention
(n = 32)
Primary care QOF 8 score
0.00–56.4
(fewer
seizure free)
6 (16.2) 9 (28.1) 1.00 (reference) 5 (13.5) 9 (28.1) 1.00 (reference)
58.3–65.4 9 (24.3) 6 (18.8) 0.72 (0.22 to 2.32) 10 (27.0) 6 (18.8) 0.62 (0.20 to 1.98)
65.5–73.6 9 (24.3) 4 (12.5) 0.44 (0.12 to 1.63) 10 (27.0) 5 (15.6) 0.50 (0.15 to 1.67)
75.9–78.9 8 (21.6) 7 (21.9) 1.02 (0.32 to 3.22) 9 (24.3) 6 (18.8) 0.72 (0.22 to 2.32)
80.0–91.7
(more
seizure free)
5 (13.5) 6 (18.8) 1.48 (0.40 to 5.44) 3 (8.1) 6 (18.8) 2.62 (0.59 to 11.58)
Seizure severity score
0–5
(least severe)
11 (30.6) 14 (43.8) 1.00 (reference) 12 (32.4) 15 (46.9) 1.00 (reference)
7.5–50 10 (27.8) 5 (15.6) 0.48 (0.14 to 1.61) 10 (27.0) 5 (15.6) 0.50 (0.15 to 1.67)
52.5–67.5 7 (19.4) 6 (18.8) 0.96 (0.28 to 3.24) 9 (24.3) 5 (15.6) 0.58 (0.17 to 1.96)
70–90
(most severe)
8 (22.2) 7 (21.9) 0.98 (0.31 to 3.12) 6 (16.2) 7 (21.9) 1.45 (0.43 to 4.90)
Seizure onset
Generalised or
unknown
17 (45.9) 13 (40.6) 1.00 (reference) 19 (51.4) 12 (37.5) 1.00 (reference)
Focal 20 (54.1) 19 (59.4) 1.24 (0.47 to 3.26) 18 (48.6) 20 (62.5) 1.76 (0.67 to 4.64)
AEDS prescribed
0 1 (2.7) 0 (0.0) 1.00 (reference) 1 (2.7) 1 (3.1) 1.00 (reference)
1 16 (43.2) 19 (59.4) 1.92 (0.73 to 5.04) 16 (43.2) 19 (59.4) 1.92 (0.73 to 5.04)
2 14 (37.8) 10 (31.3) 0.75 (0.27 to 2.05) 15 (40.5) 10 (31.3) 0.67 (0.25 to 1.816)
3–5 6 (16.2) 3 (9.4) 0.54 (0.12 to 2.36) 5 (13.5) 2 (6.3) 0.43 (0.08 to 2.40)
Depression score
0–1 (least
symptoms)
9 (24.3) 3 (9.4) 1.00 (reference) 11 (29.7) 1 (3.1) 1.00 (reference)
2–3 11 (29.7) 8 (25.0) 0.79 (0.27 to 2.31) 8 (21.6) 19 (59.4) 1.02 (0.32 to 3.22)
4–5 4 (10.8) 6 (18.8) 1.90 (0.48 to 7.53) 4 (10.8) 0 (0.0) 1.90 (0.48 to 7.53)
6–7 5 (13.5) 6 (18.8) 1.48 (0.40 to 5.44) 7 (18.9) 10 (31.3) 1.20 (0.37 to 3.92)
8–19
(most symptoms)
8 (21.6) 9 (28.1) 1.42 (0.47 to 4.29) 7 (18.9) 2 (6.3) 1.68 (0.54 to 5.22)
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TABLE 6 Baseline characteristics of study participants according to treatment group at follow-up assessment
(continued )
Baseline
measure
Treatments groups at
assessment 2, n (%)
OR (95% CI)
Treatments groups at
assessment 3, n (%)
OR (95% CI)
Comparison
(n = 37)
Intervention
(n = 32)
Comparison
(n = 37)
Intervention
(n = 32)
Anxiety score
0–4
(least symptoms)
7 (18.9) 5 (15.6) 1.00 (reference) 7 (18.9) 5 (15.6) 1.00 (reference)
5–7 9 (24.3) 10 (31.3) 1.41 (0.49 to 4.11) 8 (21.6) 10 (31.3) 1.65 (0.55 to 4.90)
8–9 8 (21.6) 3 (9.4) 0.38 (0.09 to 1.57) 8 (21.6) 3 (9.4) 0.38 (0.09 to 1.57)
10–12 7 (18.9) 8 (25.0) 1.43 (0.45 to 4.54) 7 (18.9) 8 (25.0) 1.43 (0.45 to 4.54)
13–19
(most symptoms)
6 (16.2) 6 (18.8) 1.19 (0.34 to 4.18) 7 (18.9) 6 (18.8) 0.99 (0.29 to 3.35)
QoL score
13–18
(highest QoL)
8 (21.6) 4 (12.5) 1.00 (reference) 8 (21.6) 4 (12.5) 1.00 (reference)
19–23 7 (18.9) 9 (28.1) 1.68 (0.54 to 5.22) 7 (18.9) 8 (25.0) 1.43 (0.45 to 4.54)
24–26 4 (10.8) 5 (15.6) 1.53 (0.37 to 6.32) 5 (13.5) 6 (18.8) 1.48 (0.40 to 5.44)
27–33 10 (27.0) 6 (18.8) 0.62 (0.19 to 1.98) 10 (27.0) 6 (18.8) 0.62 (0.20 to 1.98)
34–36
(lowest QoL)
8 (21.6) 8 (25.0) 1.21 (0.39 to 3.73) 7 (18.9) 8 (25.0) 1.43 (0.45 to 4.54)
Felt stigma score
0 (least stigma) 11 (29.7) 13 (40.6) 1.00 (reference) 10 (27.0) 13 (40.6) 1.00 (reference)
1–2 8 (21.6) 7 (21.9) 1.02 (0.32 to 3.22) 9 (24.3) 7 (21.9) 0.87 (0.28 to 2.71)
3–4 6 (16.2) 7 (21.9) 0.63 (0.24 to 1.67) 7 (18.9) 9 (28.1) 1.68 (0.54 to 5.22)
5–9
(most stigma)
12 (32.4) 5 (15.6) 0.39 (0.12 to 1.26) 11 (29.7) 3 (9.4) 0.25 (0.06 to 0.98)
Medication management
13–39
(lowest skills)
4 (11.1) 7 (21.9) 1.00 (reference) 5 (13.9) 6 (18.8) 1.00 (reference)
40–44 6 (16.7) 8 (25.0) 1.89 (0.62 to 5.79) 4 (11.1) 8 (25.0) 2.96 (0.85 to 10.32)
45–46 8 (22.2) 7 (21.9) 1.17 (0.40 to 3.42) 7 (19.4) 8 (25.0) 1.59 (0.54 to 4.67)
47–48 6 (16.7) 5 (15.6) 1.15 (0.35 to 3.80) 8 (22.2) 6 (18.8) 0.99 (0.33 to 2.99)
49–50
(highest skills)
12 (33.3) 5 (15.6) 0.49 (0.16 to 1.53) 12 (33.3) 4 (12.5) 0.40 (0.12 to 1.33)
Satisfaction with medication information
1–4
(least satisﬁed)
6 (16.7) 5 (16.1) 1.00 (reference) 6 (16.7) 5 (16.1) 1.00 (reference)
5–7 8 (22.2) 6 (19.4) 0.84 (0.25 to 2.78) 8 (22.2) 6 (19.4) 0.84 (0.25 to 2.78)
8–9 5 (13.9) 7 (22.6) 1.81 (0.51 to 6.47) 4 (11.1) 8 (25.8) 2.78 (0.74 to 10.46)
10–11 8 (22.2) 6 (19.4) 0.84 (0.25 to 2.78) 7 (19.4) 6 (19.4) 0.99 (0.29 to 3.38)
12–17
(most satisﬁed)
9 (25.0) 7 (22.6) 0.88 (0.28 to 2.73) 11 (30.6) 6 (19.4) 0.55 (0.17 to 1.72)
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Epilepsy care received by participants following recruitment
Assessment 2
No signiﬁcant differences existed between the two groups in the proportion of participants who reported
having consulted with a neurologist or a primary doctor, or who had accessed other hospital outpatient
services for epilepsy over the 6 months preceding assessment 2 (all p > 0.05). However, signiﬁcantly more
participants in the intervention group (n = 27, 84%; median number of appointments 1, IQR 1–2) than in
the comparison group (n = 2, 5%; OR 94.5, 95% CI 16.80 to 531.72) had seen an ENS in this time. The
median appointment duration was 45 minutes (IQR 30–60 minutes).
Signiﬁcantly more participants in the comparison group (n = 19, 51%; median number of appointments 1,
IQR 1–2) than in the intervention group (n = 7, 22%; OR 0.27, 95% CI 0.10 to 0.77) had had an
appointment with a nurse within their primary care medical practice. Participants frequently cited the
TABLE 6 Baseline characteristics of study participants according to treatment group at follow-up assessment
(continued )
Baseline
measure
Treatments groups at
assessment 2, n (%)
OR (95% CI)
Treatments groups at
assessment 3, n (%)
OR (95% CI)
Comparison
(n = 37)
Intervention
(n = 32)
Comparison
(n = 37)
Intervention
(n = 32)
Social knowledge
8–12 (lowest
knowledge)
9 (24.3) 3 (9.4) 1.00 (reference) 9 (24.3) 4 (12.5) 1.00 (reference)
13–14 10 (27.0) 9 (28.1) 1.06 (0.36 to 3.07) 11 (29.7) 8 (25.0) 0.79 (0.27 to 2.31)
15 9 (24.3) 9 (28.1) 1.22 (0.41 to 3.60) 9 (24.3) 8 (25.0) 1.04 (0.34 to 3.13)
16–20 (highest
knowledge)
9 (24.3) 11 (34.4) 1.63 (0.57 to 4.68) 8 (21.6) 12 (37.5) 2.18 (0.75 to 6.33)
Medical knowledge
15–21 (lowest
knowledge)
9 (24.3) 4 (12.5) 1.00 (reference) 9 (24.3) 5 (15.6) 1.00 (reference)
22–24 9 (24.3) 7 (21.9) 0.87 (0.28 to 2.71) 9 (24.3) 7 (21.9) 0.87 (0.28 to 2.71)
25–26 6 (16.2) 4 (12.5) 0.74 (0.19 to 2.92) 7 (18.9) 4 (12.5) 0.61 (0.16 to 2.34)
27–28 6 (16.2) 10 (31.3) 2.35 (0.74 to 7.48) 5 (13.5) 9 (28.1) 2.50 (0.74 to 8.54)
29–32 (highest
knowledge)
7 (18.9) 7 (21.9) 1.20 (0.37 to 3.92) 7 (18.9) 7 (21.9) 1.20 (0.37 to 3.92)
Mastery
6–12 (lowest
conﬁdence
10 (27.0) 7 (21.9) 1.00 (reference) 10 (27.0) 7 (21.9) 1.00 (reference)
13–14 7 (18.9) 7 (21.9) 1.20 (0.37 to 3.92) 6 (16.2) 8 (25.0) 1.72 (0.52 to 5.68)
15 5 (13.5) 7 (21.9) 1.79 (0.50 to 6.38) 4 (10.8) 7 (21.9) 2.31 (0.60 to 8.85)
16–17 6 (16.2) 5 (15.6) 0.96 (0.26 to 3.52) 8 (21.6) 5 (15.6) 0.67 (0.19 to 2.33)
18–21 (highest
conﬁdence)
9 (24.3) 6 (18.8) 0.72 (0.22 to 2.32) 9 (24.3) 5 (15.6) 0.58 (0.17 to 1.96)
Primary care QOF 8 score, percentage of PWE (aged ≥ 16 years) prescribed AEDs in the local population who were seizure free in
the previous 12 months as recorded by primary care medical practices in England in 2009–10.
p < 0.10 shown in bold; logistic regression used.
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reason for these appointments as being for AED level testing. The median duration of these appointments
was 10 minutes (IQR 5–15 minutes).
Assessment 3
The only signiﬁcant difference in the care reported to have been received over the 6 months preceding
assessment 3 was that more participants in the intervention group (n = 14, 44%) had accessed other
hospital outpatient services for their epilepsy than participants in the comparison group (n = 5, 14%; OR
4.98, 95% CI 1.53 to 16.23). These were typically noted by participants as being appointments for brain
imaging and electroencephalography, which typically arose as a consequence of having seen the ENS
(median number of appointments 1, IQR 1–2).
Uptake of the epilepsy nurse specialist-led self-management intervention
Over the entire 12-month follow-up period, 35 (80%) of the 44 participants offered the intervention
attended one or more sessions. Seventeen (39%) attended one ENS session, 12 (27%) attended two
sessions and six (14%) attended three sessions. The ﬁrst session took place on average 5 weeks
following recruitment, the second 24 weeks following recruitment and the third 38 weeks
following recruitment.
Using logistic regression, the baseline information on intervention participants did not signiﬁcantly predict
whether or not a patient received at least one intervention session (all p < 0.05).
At the time of the 6-month follow-up assessment, 29 (90.6%) of the 32 retained intervention participants
had received at least one ENS-led self-management session. At the 12-month follow-up assessment,
30 (93.8%) of the 32 retained intervention participants had received at least one ENS-led
self-management session.
Outcome analyses
Unadjusted analyses of effect of intervention on emergency department visits
To reiterate, the primary outcome assessment occurred 12 months post recruitment (assessment 3).
Unadjusted analyses indicated that the rate of ED visits reported by the intervention group at assessment 3
was 55% lower than that of the comparison group (Table 7). This difference was not statistically signiﬁcant
(p = 0.113), with groups not signiﬁcantly predicting ED use [Wald χ2 (1) = 2.52, p = 0.1127]. In addition, no
signiﬁcant difference was found in the rate of ED visits reported by the groups at the 6-month follow-up
(assessment 2). Table 8 presents the pattern of ED use reported by participants in the treatment groups at
baseline and follow-up.
No signiﬁcant effect of the intervention on subsequent ED visits was found when analyses were restricted
to include in the intervention group only those participants who had received at least one intervention
session (Table 9).
Covariates for emergency department visits and adjusted analyses of
effect of intervention
The baseline variables identiﬁed as most predictive of a greater number of ED visits following recruitment
were, in descending order of importance, lower conﬁdence in managing epilepsy (less mastery), higher
number of prescribed AEDs, more felt stigma, higher number of baseline ED visits, greater seizure
frequency and higher levels of depression and anxiety (Table 10). In multivariate analyses, greater felt
stigma and less conﬁdence in managing epilepsy remained signiﬁcantly predictive of ED visits at
assessment 3.
Including the covariates in the regression models for ED visits resulted in the models now signiﬁcantly
predicting the level of ED visits that participants reported having made 6 months [Wald χ2 (6) = 103.30,
p < 0.0001] and 12 months [Wald χ2 (11) = 140.90, p < 0.0001] following recruitment. Treatment
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allocation, however, remained a non-signiﬁcant predictor both when the data were analysed on an
intention-to-treat basis (see Table 7) and when the data were analysed on an efﬁcacy basis (see Table 9).
Effect of intervention on secondary outcomes
The effect of the intervention on the secondary outcome variables at assessments 2 and 3 is presented in
Table 7. No signiﬁcant effect of the intervention was found on any of the measures at the 12-month
outcome assessment, with and without adjustment for covariates.
No signiﬁcant effect of the intervention on the secondary outcomes was also found when analyses were
restricted to include in the intervention group only those participants who had received at least one
intervention session (see Table 9).
Summary
We tested a self-management intervention delivered by ENSs that aimed to reduce subsequent ED visits by
PWE. We compared its effect with the effect of TAU alone.
In total, 80% of the participants offered the ENS-led intervention in our study attended at least one
intervention session. This uptake rate is favourable when compared with that reported to have occurred in
previous randomised (76–95%)54,63,78,114,115 and non-randomised (48%)116 trials of nurse interventions in
the wider epilepsy population.
Recruitment for our study was slower than anticipated and the trial stopped with 69 participants instead of
the planned-for 120. This is reﬂected in wider CIs for the key estimates and consequent ambiguity in some
conclusions. The results from our adjusted analyses are, nevertheless, evidence against the possibility of the
intervention leading to a large (50%) reduction in number of ED visits. No effects on the secondary
psychosocial outcome measures were found.
Results from our analyses of baseline predictors of subsequent ED use suggest that, to improve patient
outcomes and reduce visits, interventions may need to focus more on patients' perceptions of
stigmatisation because of epilepsy, conﬁdence in managing epilepsy, psychological distress and
epilepsy knowledge.
TABLE 8 Emergency department visits for epilepsy reported at baseline and at follow-up assessments
Assessment point
ED visits in the last 12 (baseline) and 6 (assessments 2 and 3) months, n (%)
0 1 2–3 ≥ 4
Baseline
Comparison (n = 41) 0 15 (36.6) 13 (31.7) 13 (31.7)
Intervention (n = 44) 0 18 (40.9) 15 (34.1) 11 (25.0)
Assessment 2
Comparison (n = 37) 23 (62.2) 6 (16.2) 4 (10.8) 4 (10.8)
Intervention (n = 32) 13 (40.6) 10 (31.3) 7 (21.9) 2 (6.3)
Assessment 3
Comparison (n = 37) 23 (62.2) 4 (10.8) 6 (16.2) 4 (10.8)
Intervention (n = 32) 22 (68.8) 3 (9.4) 6 (18.8) 1 (3.1)
Frequency of ED visits was overdispersed at both 6 months [mean 1.12 < variance 4.34; χ2 (1) = 50.93, p < 0.001] and
12 months [mean 1.13 < variance 7.65; χ2 (1) = 111.65, p < 0.001].
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TABLE 10 Association between baseline variables and number of ED visits made by participants over follow-up
Baseline measure
Assessment 2 Assessment 3
Unadjusted IRR
(95% CI)
Adjusted IRR
(95% CI)
Unadjusted IRR
(95% CI)
Adjusted IRR
(95% CI)
Gender (0 = female; 1 =male) 0.69 (0.31 to 1.55) – 0.97 (0.30 to 3.12) –
Age (years) 0.99 (0.98 to 1.02) – 1.01 (0.98 to 1.02) –
Ethnicity (0 =white British;
1 = other)
1.30 (0.52 to 3.25) – 2.40 (0.84 to 6.87) –
Education (years) 0.92 (0.80 to 1.06) – 0.94 (0.82 to 1.09) –
Deprivation (higher =more
deprivation)
0.97 (0.93 to 1.01) – 0.99 (0.93 to 1.06) –
Comorbidity (0 = none;
1 = present)
0.94 (0.40 to 2.22) – 1.32 (0.45 to 3.83) –
Duration of epilepsy (years) 0.99 (0.97 to 1.02) – 0.99 (0.97 to 1.03) –
Emergency visits last
12 months
1.14 (1.10 to 1.19) 1.14 (1.03 to 1.26) 1.19 (1.10 to 1.29) 1.05 (0.92 to 1.20)
QoL (higher = poor QoL) 1.04 (0.99 to 1.10) – 1.09 (1.02 to 1.16) 0.93 (0.86 to 1.01)
Seizure frequency 1.09 (0.97 to 1.23) – 1.19 (1.03 to 1.38) 0.91 (0.80 to 1.02)
Primary care QOF 8 score
(higher =more seizure free)
1.01 (0.98 to 1.03) – 0.98 (0.96 to 1.01) –
Seizure severity
(higher =more severe)
1.01 (0.99 to 1.02) – 1.03 (1.01 to 1.04) 1.02 (0.99 to 1.03)
Seizure localisation
(0 = generalised or unknown;
1 = focal)
0.55 (0.24 to 1.24) – 0.66 (0.23 to 1.96) –
Number of AEDs prescribed 1.56 (1.13 to 2.15) 0.98 (0.68 to 1.41) 1.69 (1.18 to 2.44) 1.43 (0.83 to 2.47)
Depression (higher =more
symptoms)
1.12 (1.04 to 1.20) 0.99 (0.88 to 1.12) 1.16 (1.07 to 1.25) 0.99 (0.87 to 1.14)
Anxiety (higher =more
symptoms)
1.13 (1.04 to 1.23) 1.02 (0.94 to 1.11) 1.10 (0.99 to 1.22) –
Felt stigma (higher =more
felt stigma)
1.14 (1.01 to 1.30) 0.97 (0.82 to 1.10) 1.42 (1.19 to 1.69) 1.32 (1.11 to 1.56)
Medication management skills
(higher = better skills)
0.97 (0.92 to 1.03) – 1.01 (0.96 to 1.06) –
Satisfaction with medication
information (higher = increased
satisfaction)
0.93 (0.83 to 1.04) – 0.89 (0.77 to 1.04) –
Medical knowledge
(higher =more knowledge)
0.95 (0.87 to 1.03) – 0.92 (0.83 to 1.02) –
Social knowledge
(higher =more knowledge)
0.88 (0.71 to 1.09) – 0.80 (0.60 to 1.06) –
Mastery (higher =more
conﬁdence in
managing epilepsy)
0.85 (0.78 to 0.93) 0.95 (0.87 to 1.04) 0.77 (0.70 to 0.84) 0.86 (0.77 to 0.96)
Model summary χ2 (6) = 43.69,
p < 0.0001
χ2 (8) = 120.91,
p < 0.0001
Primary care QOF 8 score, percentage of PWE (aged ≥ 16 years) prescribed AEDs in the local population who were seizure free in
the previous 12 months as recorded by primary care medical practices in England in 2009–10.
p < 0.05 shown in bold; NBR used.
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Chapter 3 Qualitative component
A qualitative study was nested within the non-randomised trial. Qualitative methods allow issues ofimportance for patients to be identiﬁed and examined in depth117 and were used here to explore two
main topics with participants. The ﬁrst concerned patients' reasons for attending an ED for epilepsy, and
the second addressed participants' views of the ENS-led self-management intervention, including how it
compared with usual care and satisﬁed their perceived support needs.
For the qualitative study, semistructured interviews were completed with a subsample of participants from
the intervention group and the TAU group. Participants from the intervention group were interviewed both
about their reasons for attending an ED for epilepsy and about the intervention, whereas those from the
TAU group were interviewed only about their reasons for attending an ED for epilepsy.
We have split this chapter into two sections. The ﬁrst section presents explanations given by PWE for using
emergency medical services, and the second describes their views of the intervention. We describe the
methods used in the ﬁrst section only.
STUDY 3: QUALITATIVE STUDY OF PATIENTS' VIEWS, EXPERIENCES
OF THE SERVICE AND REASONS FOR ATTENDING THE EMERGENCY
DEPARTMENT STUDY
We aimed to explore the perspectives of adults with epilepsy who had attended the ED about who had
made the call for emergency medical services and their rationale.
Methods
Recruitment for nested qualitative study
To avoid biasing the questionnaire responses, participants for this nested study were interviewed after they
had returned the 12-month follow-up questionnaire for the trial. Interviews were conducted until
responses indicated that the saturation point had been reached and no further interviews were required.
The ﬁrst 24 trial participants who sequentially completed the ﬁnal follow-up were invited for interview.
Procedure
Interviews were conducted by a researcher independent of the trial and intervention (CV; please see
acknowledgements section). Depending on each participant's preference, interviews were undertaken at
their home or in our university ofﬁce. The majority of interviews lasted for 1 hour (IQR 44–69 minutes).
If the participant asked for a family member or ‘signiﬁcant other’ to be present at the interview, this was
agreed by us.
The topic guide was informed by a literature review and four open interviews with PWE not involved in the
trial but who had attended an ED because of their epilepsy and seen the ENS more generally.
To explore patients' reasons for attendance, the topic guide ﬁrst required the interviewer to ask
participants to recall their most recent epilepsy-related attendance at the ED, the circumstances leading to
the attendance, who made the decision to call the emergency medical services and whether attendance
was the users' preference or not. Those participants who had received the intervention were then asked
about their experiences of the intervention; whether they found it helpful and, if so, how and why; and
whether they felt that any improvements could be made to the intervention. Throughout the interview,
participants were encouraged to talk freely, with the interviewer probing and prompting responses
as required.
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Data analysis
Interviews were audio recorded and transcribed verbatim. Data were analysed thematically117 using the
software package NVivo 9 (qSR International, Southport, UK). The researchers AN and CV read each
transcript line by line and generated codes through open coding and then categorised these thematically.
Relationships between themes were then identiﬁed through constant comparison of the transcripts, codes
and categories. LR and MM reviewed the codes and their application and suggested alternative
interpretations, and further interrogation of the data was undertaken until consensus was reached about
explanations, relationships and inﬂuences on behaviours.
Results
Of the 24 participants identiﬁed, 19 (80%) agreed to be interviewed. Two were not contactable, one had
died, one was too busy to meet and one refused to be interviewed. The sample interviewed included
patients of varying ages, ethnicities, epilepsy duration, seizure frequency and reported ED use in the last
year (Table 11). Sixteen of the participants interviewed were from the trial intervention group and three
were from the TAU comparison group.
Analysis of patients' reasons for attending the ED identiﬁed three major themes: (1) context and presence/
absence of a ‘signiﬁcant other’; (2) patients' perspective on whether calling the emergency medical
services was the right choice; and (3) how patients deﬁned ‘an emergency’. Quotations are presented to
illustrate the themes and data extracts are anonymised.
Theme 1: context and presence/absence of a ‘significant other’
Participants distinguished between seizures that occurred within the home and seizures that
occurred elsewhere.
Seizures occurring within the home
Approximately half of the respondents (9/19) reported that their most recent seizure occurred within the
home. For most of these participants, the family members/signiﬁcant others were key contributors towards
the decision to attend the ED. Three participants described their signiﬁcant others as familiar with their
epilepsy and having witnessed seizures before. Patients described the way that their signiﬁcant others'
conﬁdence/knowledge meant that they were in control in the event of a seizure:
He [patients’ son] has seen that type before ’cos he had to call them [emergency services] regularly.
About a year and a half ago I was having them every day, but I did say to him, I said time it before
you call them. I said if it’s under five minutes, leave it, just go find a neighbour, but if it’s more than
five minutes, then yes call them.
Participant number 15 (female, 34 years)
These patients stated that, because their signiﬁcant others were aware of what actions to carry out in the
event of a seizure, their decision to contact medical help was based on whether they were regarded as
requiring emergency care. One said:
Because it had been quite a while and because I hadn’t presented with vomiting before. So it was
obviously the new dimension of it that led me to call the ambulance.
Participant number 8 (male, 21 years)
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Four patients and one accompanying friend described how the signiﬁcant others had witnessed a seizure
before but described them on that occasion as being uncertain of what was required. As a result they
regarded emergency medical services as a safer option. For example, an accompanying friend said:
[I] just worried because I don’t know anything about epilepsy and I don’t . . . I mean I only know the
bad things, I know it can be quite serious and things like that, and I know you can die from it so I
decided . . . I was so worried I decided just to ring an ambulance . . . better safe than sorry.
Female friend of participant number 16 (female, 60 years)
There were two participants who had had a seizure at home and who lived alone. One said that living
alone made her feel more vulnerable and fearful and so she sought medical attention on a routine basis:
I was afraid I might die, because it could kill. [I] want to talk to someone; I want to see people around
me, just other people who can care for me.
Participant number 6 (female, 68 years)
The other described how she had support from her neighbours, with decisions to seek medical help arising
from their uncertainty about the situation:
They were worried, they called the ambulance.
Participant number 4 (female, 91 years)
Seizures occurring outside the home
Nine respondents (9/19) reported that their most recent seizure that led to an emergency call and ED
attendance occurred outside the home. In these circumstances many respondents described decisions to
seek medical care as being made by someone outside their usual home-based network of family/friends,
such as bystanders, work colleagues or the police.
Three respondents had had their recent seizure in the workplace. These respondents described having
conﬁdence in their work colleagues to make the right decision in the event of a seizure. This was based on
them telling their work colleagues about their condition beforehand, to increase the possibility that they
could provide ﬁrst aid and decide whether calling the emergency medical services was necessary:
Usual routine is to lie patient on floor, time how long, if more than 5 minutes they phone the
ambulance . . . because it is just round the corner.
Participant number 3 (female, 45 years)
Two participants had experienced their most recent seizure whilst on public transport. They reported relief
when the decision was made by the public to contact the emergency medical services based on the
unpredictability of their condition, their physical appearance/presentation of the seizure and their belief
that the public have a social responsibility to call for medical help:
I’d have thought they were absolutely shocked and terrified . . . I gather it was quite unpleasant to
watch. I don’t feel anything, but you know, you kind of make the noise and you go rigid and shake
and fall on the floor. Sometimes you bite your mouth so it probably looks, kind of, there is blood
there. So I’d imagine someone just next [saying] ‘stop, stop the train’, and call someone.
That’s quite obvious.
Participant number 12 (female, 34 years)
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Four participants explained that their most recent seizure occurred whilst they were on the street and/or in
view of the public. They felt that, as they were in public, the public's responsibility was discharged by
contacting the emergency medical services:
Well I suppose if someone just fell over on a balcony and didn’t get up, you might think that you
should probably call A&E [ED]. Kind of just something you do in the neighbourhood. I mean it was a
classic kind of thing to do something, although not want to get involved, ’cos when the ambulance
people turned up, he just walked off. So you know, I probably imagine that lots of people, perhaps
me too, would do the same. You know, arrange for some emergency service to take up and take
over, and then you just think, right, well I’ve done my bit [laughs].
Participant number 1 (male, 33 years)
Theme 2: perspectives on whether use of the emergency department was
the ‘right choice’
Preference to attend the emergency department
Most participants reported that it was the right choice for either their signiﬁcant other or those outside
their social network (i.e. the public) to have contacted the emergency services. Some patients felt
personally that it would not have been the choice that they would have made, but they regarded it as the
right choice in the given situation that justiﬁed other peoples' decisions as the right course of action:
I was with my friend, so she was scared and she doesn’t know what to do, you know, she was lost.
So she needed to call the ambulance. And when they came around, I was still in it. [I] don’t always
like going into A&E, but she called them, so there was absolutely nothing I could do to stop them
from doing their job.
Participant number 18 (female, 31 years)
Some participants believed that it was the right choice to attend the ED, based on the seizure or its
consequences needing emergency medical care, particularly when treatment was required for injuries or
new symptoms:
I mean I think in most circumstances whether there are new symptoms, you know . . . as soon as I
can, and you know . . . A&E is the most appropriate thing, that’s fine.
Participant number 8 (male, 21 years)
Another person felt that it was the right choice based on the fear of sudden death and the need
for reassurance:
I don’t want to die. [A]nything could happen, you see this epilepsy can happen to you, anywhere you
know. So, happy to call 999 for me.
Participant number 17 (male, 37 years)
Preference to avoid the emergency department
Although most patients justiﬁed the reasons for calling the emergency medical services, three participants
highlighted that it was either a situation in which they had no choice, or a decision that was not required
as they had learnt to accept their condition and felt that the ED had little to offer. They thought that they
would beneﬁt more from recovering within the comfort of their own home:
There’s not a lot they can actually do. Most times on arrival, you’re aware, and they cannot offer you
any more; wasting space for somebody else who can go ahead and use that.
Participant number 2 (male, 47 years)
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Another participant described a level of medical care that was too much for her:
’Cos I feel like it’s a fuss ’cos I’m there. It’s only a fit I’ve had, ’cos I’ve got used to it now and I’m
thinking they don’t need to fuss round me and putting all these things on me when I know I’m OK
. . . don’t need it.
Participant number 13 (female, 47 years)
Theme 3: describing what ‘an emergency’ was generally
Most participants (n = 13) stated that only in particular medical circumstances would they feel that
emergency medical services were required. Ten respondents mentioned speciﬁc criteria to use to determine
when it was appropriate to call an ambulance. One said:
injury is the only cause I see for medical attention really to be checked over. If it’s something minor,
it doesn’t need medical attention, it wastes hospital time.
Participant number 10 (male, 26 years)
However, many respondents proposed a broader social deﬁnition of an emergency state, which was
inﬂuenced by the presence or absence of their signiﬁcant others. They identiﬁed that, if their network
of family/friends were present and able to cope, then calling the emergency medical services would
not be necessary:
If I was at home then me mum can turn around and say to herself ‘right I can cope with that . . . I’ll
just stick her to bed’.
Participant number 3 (female, 45 years)
They described that their ED attendance was necessary when their signiﬁcant other was absent, sometimes
because the signiﬁcant other was responsible for delivering their medication, as this respondent explained:
But if I’m not at my mum’s and have one here, I always call the ambulance. [T]hat’s why, Dr [Name]
gave me diazepam to give to my mum. So if I go in one, she shoots it up to me, and then I come
out of it.
Participant number 19 (male, aged 23 years)
Three respondents regarded calling the emergency medical services as routine. They expressed fear of the
risk of sudden, unexpected death, possibly exacerbated by living alone, with no support network and poor
knowledge of the condition. One said of her seizures:
Felt this thing was catching me, afraid I might die, and no one knows, that is why.
Participant number 6 (female, aged 68 years)
Summary
From the patients' perspective, use of emergency service pathways is appropriate when they are away
from home or do not have someone who knows about seizure management nearby.
Hospitals providing regular sessions on seizure management might increase knowledge and conﬁdence
among patients and their supporters, as well as fostering participation by PWE. Future research should be
designed to develop and evaluate this.
DOI: 10.3310/hsdr01090 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 9
43
© Queen's Printer and Controller of HMSO 2013. This work was produced by Ridsdale et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
STUDY 4: PATIENTS' VIEWS AFTER 1 YEAR OF FOLLOW-UP OF THE
EXTENT TO WHICH THE EPILEPSY NURSE SPECIALIST-LED
SELF-MANAGEMENT INTERVENTION MET THEIR NEEDS
In Chapter 2 we presented the ﬁndings from our trial of the effect of an ENS-led self-management
intervention on subsequent ED use and patient well-being. Full evaluation of complex health interventions,
however, requires consideration of issues in addition to effectiveness.118 This includes the acceptability of
the intervention to patients, barriers to and facilitators of its uptake, and the beneﬁts and costs perceived
by patients. Such information can be used to inform treatment reﬁnement. Data from the interviews with
the intervention participants were used to address the following speciﬁc questions, which are important
for a patient-based evaluation of the ENS-led self-management intervention:
1. Was the intervention valued by patients and, if so, why? Some have suggested that PWE who attend
the ED might be reluctant to accept and engage in additional treatment41,119
2. Were any aspects of the intervention perceived by patients as particularly helpful or unhelpful and, if so,
why? The intervention was ‘complex’, and identifying what were the ‘active ingredients’ of the
intervention might help with future service development120
3. Did all patients who saw the ENS perceive similar beneﬁts and limitations of the intervention or did it
depend on speciﬁc participant characteristics?
Methods
The methods used have been described in the previous section. To answer the questions in this study, only
the data from the 16 intervention participants (participants 4–19) (see Table 11) were analysed.
Results
Analysis of the transcripts provided insights into the effects of the intervention and how these occurred.
Four key themes were identiﬁed. These were limitations of usual care; what the ENS-led self-management
intervention added; speciﬁc ways that the intervention had helped; and some reasons why, for some
participants, the intervention had a more limited beneﬁt. Quotations are presented to illustrate themes.
There has been minor editing of some to preserve anonymity and ensure meaning of extracts.
Theme 1: limitations of usual care
Participants consistently highlighted that their usual epilepsy care had not equipped them with sufﬁcient
information about epilepsy despite having typically been diagnosed with epilepsy for ≥ 5 years. Many
described this as contributing to them lacking conﬁdence in self-management. Participants described how
they had often left usual care consultations with unresolved questions and uncertainties:
They told me it was epilepsy, but they didn’t explain what it really meant . . . I didn’t know whether it
was affecting me personally, or my brain, or what. I didn’t know.
Participant number 4 (female, 91 years)
Primary care doctors were felt to be available for patients to see but to be often lacking in expertise in
epilepsy to enable them to satisfactorily answer their questions:
When you go to your family doctor and you ask them a question, they say, ‘Oh I don’t know, why
don’t you hold that question for when you next see your consultant’, which is twice a year!
Participant number 15 (female, 34 years)
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Hospital specialists, on the other hand, were frequently perceived to be poor listeners and not interested in
the patient's perspective, or the wider psychosocial difﬁculties that patients were experiencing whilst living
with epilepsy:
When I go and see my consultant, there’s very much a sort of, ‘Right, this is your condition, this is
what we’re going to do. Any questions? No. All right.’
Participant number 8 (male, 21 years)
Theme 2: what the epilepsy nurse specialist-led self-management
intervention offered and how it was different
All but one participant reported having valued or even enjoyed the experience of the intervention to
some degree:
A generally very useful conversation. Ten out of ten.
Participant number 9 (male, 59 years)
First, it helped satisfy some participants' need for information about epilepsy:
She knew her subject very well. Whenever I asked a question, she was able to respond straightaway
. . . I think that’s a lot better service.
Participant number 12 (female, 34 years)
Sessions were also perceived to be more relaxed. This helped participants to feel able to ask questions and
to be involved in the content of their care:
It was less formal than with the doctor. You felt that you could actually ask questions . . . With [nurse
name] I felt it was far more about me . . .‘What do you want to know about?’
Participant number 8 (male, 21 years)
Participants appreciated the empathic approach adopted by the ENSs and valued their attention to the
often broad challenges of living with epilepsy:
[Nurse name] is more helpful than my doctor. We talked about everything, about epilepsy and fertility,
about sex . . . She introduced me to a support group for epilepsy. Suggested I go for counseling
and so many things like that. But Dr [Name] will always talk to me only about epilepsy. Never the
wider aspects.
Participant number 18 (female, 31 years)
The longer length of the nurse-run sessions compared with usual care was also valued as it permitted
information to be thoroughly explained, and also meant that complex challenges in patients' lives could be
explored and needs identiﬁed:
I have had chronic pelvic pain that goes back to when I gave birth to my son fourteen years ago . . .
She [the nurse] asked physio if they could see me as a priority because the pain affects my sleep
which affects my epilepsy, and then we have this constant circle. They did see me. They’ve discharged
me now, but I’m maintaining it. If I can handle the pelvis, I can handle the epilepsy.
Participant number 15 (female, 34 years)
The nurses offered participants their ofﬁce telephone number. Some commented on the usefulness of this
as it meant that they had access to rapid support in managing challenges from their epilepsy as they arose.
DOI: 10.3310/hsdr01090 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 9
45
© Queen's Printer and Controller of HMSO 2013. This work was produced by Ridsdale et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
Theme 3: specific benefits that participants received from the intervention
Reﬂecting the intended responsive nature of the intervention, a variety of beneﬁts were identiﬁed
that involved emotional well-being, ability to take antiepileptic medication and conﬁdence in
managing seizures.
The number of domains in which a participant perceived beneﬁt to have occurred and the magnitude of
this beneﬁt was broadly linked with the number of ED visits that he or she reported having made in the
year before trial recruitment, with those who had used the ED the most describing more beneﬁt. In
contrast, participants who had used the ED once in the last year typically reported fewer beneﬁts and they
tended to be restricted to emotional well-being. There was no suggestion that duration of epilepsy exerted
a similar inﬂuence.
Emotional well-being
Eleven participants described having experienced a variety of emotional difﬁculties as a result of epilepsy.
Eight considered that the intervention had had a positive impact on these. They described the intervention
as being the ﬁrst time that they had been asked about how they felt about their epilepsy, and it provided
an opportunity for them to ‘get these things out and off one's shoulders’ (participant number 9). Some felt
more comfortable with their diagnosis as a result:
I’m confident now . . . she made me into someone with the confidence to talk about it. It’s really
helped me talking about it. [T]he shame of myself as an epileptic patient has also drastically reduced.
Participant number 18 (female, 31 years)
One aspect that these participants identiﬁed as being particularly helpful in such adjustment was being
provided with information about how common epilepsy is.
Ability to take antiepileptic medication
Half of the participants volunteered that they had previously experienced difﬁculties in taking their AEDs.
Of these, six felt that the intervention had helped them, although how it helped varied. For some this
included being taught strategies to help them to remember to take their tablets, whereas for others it was
being educated about the importance of regular dosing and adhering to the prescribed regime:
She pointed out, you know, it’s not just daily, but it’s got to be at a certain time every day . . . I wasn’t
as good at timings . . . I’m not perfect with it now, but I do try to take it at the same time every day,
in the morning and in the evening. That was kind of drummed home to me.
Participant number 12 (female, 34 years)
Participants also highlighted the importance of the nurse reviewing their medication(s) and their responses
to them. For one patient this resulted in troublesome adverse effects being identiﬁed and, with the
involvement of her primary care doctor, the individual switched to another AED.
Confidence in managing seizures
Seven participants reported having felt fearful about their seizures and the potential consequences:
Cancer, you’re awake. I know you can die, but you’re awake. I’d prefer something like that . . .
Having epilepsy, you’re going into a fit. You don’t know if you’re going to wake up or die.
Participant 19 (male, 23 years)
As well as restricting their social activities, participants described how this often led them to call for an
ambulance when they believed that they were about to have, or had had, a seizure, regardless of whether
the seizure involved complications. Four participants felt that, through the provision of information about
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seizures, triggers, risk management and appropriate ﬁrst aid, the intervention helped them feel more
conﬁdent in managing seizures, and knowing when it was necessary to seek emergency care:
Now I don’t feel as if I need to go to hospital . . . I’m not so frightened of it . . . I was really frightened
of it.
Participant number 16 (female, 60 years)
Participants reported that the nurse highlighted the possibility of wearing an epilepsy identiﬁcation bracelet
and/or carrying a card. Some described these items as giving them more conﬁdence. As a result their
epilepsy did not restrict them as much as before, because they did not feel the need to be accompanied by
a carer who could explain their diagnosis to others should a seizure occur.
Theme 4: why for some the benefits were more limited
People with epilepsy who reported at baseline having used the ED on only one occasion reported the
fewest beneﬁts. The main reason given for this was that, although they felt that usual epilepsy care had
not addressed all of their support needs, they believed that they had the capability, disposition and/or
conﬁdence to overcome these limitations by themselves. One said:
This is going to sound terrible . . . I think it [the intervention] is absolutely vital for somebody who is less
intelligent, less self-aware; less inquisitive . . . I’m not trying to be pejorative or anything . . . I’m just saying
that, you know, if I don’t understand something, I go out and I find out about it . . . I’m a ‘why’ person.
Participant number 5 (male, 56 years)
These people felt that their epilepsy was not as ‘severe’ as that of others and that for them the experience
of seizures and use of the ED was atypical. The seizures that led to these participants' ED visits were mostly
described as being precipitated by an unusual event in their life, such as a virus or stress:
I’m totally independent. Don’t need any looking after whatsoever . . . I am not the normal
‘run-of-the-mill’ in terms of people with epilepsy that you’ll see at the emergency department . . . I
had been at home. Been working really hard. I’d been out to a party the night before. Was stressed
out with all sort of things . . . I was in the bathroom in the morning . . . fell down . . . hit my head
and [partner’s name] came and said, ‘Oh, you know, that’s a hospital job’ . . . first time in a long,
long time.
Participant number 9 (male, 59 years)
Summary
We have reported that the trial results ruled out the possibility that a brief ENS-led self-management
intervention delivered on an outpatient basis could lead to a large reduction in subsequent ED use by PWE.
To more fully understand the utility of ENS-led self-management interventions and how PWE who attend
ED should be supported, we have described here the intervention from the perspective of patients. We
found that the intervention satisﬁed most patients and identiﬁed what they valued about it. Our
participants valued the intervention as it redressed limitations in their usual epilepsy care. Those who had
previously used the ED more perceived the greatest beneﬁts.
Not only is a self-management intervention delivered by ENSs seemingly acceptable to PWE who attend
the ED, but there was also evidence suggesting that, with optimisation, such an intervention might reduce
the number of ED visits, as some patients perceived improvements in domains that may be linked to ED
use by PWE. If this succeeded in liberating anything up to six-seventh more resources than are currently
spent on emergency hospitalisation for other epilepsy services, this could justify more research in terms of
an efﬁciency saving, as well as enhancing patient-related outcomes. The question of health economic
outcomes is taken up in Chapter 4.
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Chapter 4 Health economics component
STUDY 5: AN ECONOMIC EVALUATION OF THE PREVIOUS SERVICE
USE REPORTED BY PEOPLE ATTENDING THE EMERGENCY
DEPARTMENT FOR EPILEPSY AND OF THE COST-EFFECTIVENESS
OF THE EPILEPSY NURSE SPECIALIST-LED SELF-MANAGEMENT
INTERVENTION
The economic evaluation aimed to describe the current costs of care for this patient group who attend the ED,
and compare the cost-effectiveness of the ENS-led self-management intervention with that of TAU alone,
primarily from a health-care perspective but with the inclusion of lost employment costs in further analyses.
Methods
This study entailed combining data on health service costs with appropriate outcomes. Given the need to
provide suitable information for commissioning and policy-making, we followed NICE recommendations
and used quality-adjusted life-years (QALYs) as the main outcome measure in the economic evaluation.
As a secondary aim, we analysed baseline data to identify patient characteristics that were associated with
service costs.
Costing
Contacts with the intervention nurses were collected centrally and other service use was measured with
the Client Service Receipt Inventory (CSRI) for the 12 months before the baseline assessment and the
6 months before the 6-month and 12-month follow-ups.95 The CSRI was interviewer administered with
service use information self-reported by participants. Services included secondary care, primary care and
social care. Data were collected on whether or not a service was used, the number of contacts and (when
relevant) the typical contact duration. For inpatient care the number of days spent in hospital was
recorded. Medication taken as a result of epilepsy was recorded at each time point. The CSRI also asked
for information on lost work days (for those in employment) because of health problems.
Service costs were calculated by combining the service use data with appropriate national unit cost
information. For most services, unit costs were obtained from the annual compendium from the University
of Kent.121 Medication costs were taken from routine Prescription Cost Analysis data.122 Lost production
was valued by combining lost work days with the national average wage rate.123
Benefit measurement and valuation
The National Institute for Health and Clinical Excellence recommends that, when possible, economic
evaluations use QALYs as the outcome measure. QALYs combine information on quantity of life and
health-related QoL, with the latter measured on a scale anchored by 1 (full health) and 0 (death). The
European Quality of Life-5 Dimensions (EQ-5D)124 combined with UK weights125 was used to generate the
health-related QoL scores at baseline and each follow-up point. The total QALYs accrued for each were
calculated using area under the curve methods, and QALYs were compared between the two groups using
a linear regression model adjusting for baseline health-related QoL.
Baseline analyses
Baseline costs represent the costs of caring for patients with epilepsy prior to the intervention being
provided. Use and costs of different services were described and variables associated with cost variations
were identiﬁed using a generalised linear model with (1) service costs and (2) service costs plus lost
employment costs used as the dependent variables. Independent variables included in the model were
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age, gender, ethnicity, marital status, duration of illness, type of seizure at onset, current type of seizures,
presence of psychiatric/neurological comorbidities and presence of learning disabilities. The cost data were
positively skewed and we speciﬁed a gamma distribution in the model. The relationship between
independent variables and cost was assumed to be additive and we therefore used an identity link
function. Patients were recruited from three centres and, to account for the potential dependence
between patients within sites, we used the cluster option in the (Stata) model.
Follow-up analyses
Total service costs for the 12-month follow-up period were compared between the two groups using a
linear regression model with adjustment for baseline service costs. As before, bootstrapped 95% CIs were
generated around the regression coefﬁcient representing the cost difference.
Health-care costs were combined with the QALY data in the form of an incremental cost-effectiveness
ratio (ICER), calculated by dividing the incremental costs for the intervention group compared with the
comparison group by the incremental QALY gain. The ICER is thus based on point estimates of cost and
outcome differences. To address uncertainty round the ICER we generated 1000 resamples using
bootstrapping with replacement and calculated cost and outcome differences for each resample. These
1000 cost–outcome pairs were plotted on a cost-effectiveness plane.
To aid interpretation of the results we generated cost-effectiveness acceptability curves (CEACs) using the
net beneﬁt approach. The latter is deﬁned for each participant as the monetary value of the outcome (i.e.
QALYs accrued) minus the cost of achieving this. A range of monetary values for a QALY gain were used,
from £0 to £80,000, in increments of £5000. For each value, a regression model was used to estimate the
difference in net beneﬁt between the groups. Bootstrapping was used to generate 1000 regression
coefﬁcients for each model and the proportion of these that exceeded 1 represented the probability that
the intervention was the most cost-effective option at that particular monetary value of 1 QALY. This
information was plotted on a chart to produce the CEACs.
Data related to, at most, a 1-year period and so discounting of costs or outcomes was not applied.
All analyses were performed using Stata 11.
Results
Baseline analyses
During the 12 months before baseline all participants had ED contacts (Table 12). Around one-quarter of
participants spent time as an inpatient and for these the average time in hospital was around 5 days.
Relatively high numbers of participants also spent time in the clinical decision unit (which is a short-stay
hospital unit attached to the ED), had outpatient contacts and saw a GP. In total, 47 (55.3%) of the 85
patients had been admitted to an inpatient hospital ward and/or an ED clinical decision unit for epilepsy in
the previous 12 months. Nearly all took some form of epilepsy-related medication. Inpatient stays and time
in the clinical decision unit accounted for 43% of service costs. ED visits accounted for 7% of total service
costs, and medication accounted for 19%. The cost of lost employment was relatively low.
From Figure 3 it is clear that the costs were heavily skewed. One patient was an extreme outlier because of
an extended period of time in hospital and this individual's data were excluded from the analysis of baseline
costs. Table 13 shows the mean costs for the remaining 84 patients. Costs did not differ substantially by
demographic characteristics; however, costs were lower for younger patients and for those who were
divorced/separated. Costs appeared to follow a U-shaped distribution in relation to illness duration.
The regression of service costs on patient characteristics revealed that black and ethnic minority patients
had costs that were on average £733 (95% CI £401 to £1065) higher than the average for white British
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TABLE 12 Use and costs of services and lost employment costs in the 12 months before recruitment
Service n (%) Mean (SD) no. of contacts Mean (SD) cost (£)
ED 85 (100) 3.2 (7.7) 155 (176)
Inpatient stays 20 (24) 4.8 (7.7) 452 (1690)
Clinical decision unit 41 (48) 1.8 (1.5) 502 (795)
Neurology outpatient 57 (67) 2.4 (1.8) 237 (276)
Other outpatient 34 (40) 3.1 (2.9) 185 (354)
Day care 3 (4) 3.0 (1.7) 16 (91)
GP contacts 73 (86) 6.7 (8.3) 210 (283)
Epilepsy nurse 0 (0) – 0 (0)
Practice nurse 29 (34) 2.1 (2.1) 8 (17)
Physiotherapist 5 (6) 6.0 (10.1) 6 (38)
Social worker 6 (7) 6.0 (9.9) 14 (68)
Medication 81 (95) – 425 (393)
Total health- and social-care cost 2210 (2328)
Lost work days 19 (22) 8.1 (8.7) 145 (421)
Total cost 2355 (2455)
Note: costs in UK£ 2010–11.
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FIGURE 3 Distribution of baseline costs.
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TABLE 13 Service costs and total costs by demographic
and clinical characteristics
Characteristic Service cost (£) Total cost (£)
Age (years)
< 26 1674 1810
26–50 2182 2376
> 50 2114 2114
Gender
Male 2061 2119
Female 2021 2238
Ethnicity
White British 2068 2232
Other 2005 2081
Marital status
Single 2069 2216
Cohabiting/married 2055 2181
Divorced/widowed 1776 1776
Illness duration (years)
< 6 2146 2297
6–10 1787 1993
11–20 1548 1718
21–30 2776 2829
> 30 2326 2351
Seizure onset
Undeﬁned 1883 1954
Focal 2044 2178
Generalised 2209 2388
Seizure type
Partial 2422 2555
Generalised 1974 2069
Combination 2102 2273
Undeﬁned 1574 1634
ED site
STH 2046 2137
KCH 1935 2077
UHL 2320 2471
Comorbidity
No 1909 2043
Yes 2177 2303
Learning disabilities
No 1982 2113
Yes 2712 2826
Note: costs in UK£ 2010–11.
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patients. Total costs were also higher (by £714 on average) for black and ethnic minority patients (95% CI
£384 to £1045), for women (difference £709; 95% CI £44 to £1374), for those whose initial seizure had
an undeﬁned onset compared with a focal onset (difference £733; 95% CI £11 to £1348) and for those
whose current seizures were partial rather than undeﬁned (difference £2398; 95% CI £605 to £4192).
Other differences were non-signiﬁcant and much of the cost variation was unexplained by the
characteristics that we measured.
Follow-up analyses
During the ﬁrst 6 months of the follow-up period, more participants in the intervention group had ED
contacts than participants in the comparison group, but for those who did, the number of contacts was fewer
and this resulted in lower ED costs for the intervention group (Table 14). A similar number in each group had
inpatient stays but these were longer for the comparison group and hence the costs of inpatient care were
527% higher for the comparison group than for the intervention group. Costs of other services were similar,
and total service costs for the intervention group were 27% lower than for the comparison group.
In the 6 months before the 12-month follow-up there was little difference in ED use and costs, but there
remained a difference in inpatient costs, which were lower for the intervention group (Table 15). Total
service costs for the intervention group were 16% lower than for the comparison group.
The mean total service cost over the entire follow-up period was £2948 for the comparison group and
£2202 for the intervention group. The difference in mean costs, adjusted for baseline costs, was £558,
and this was not statistically signiﬁcant (bootstrapped 95% CI −£2409 to £648).
Over the follow-up period the QALY gain for the intervention group was 0.786 and that for the
comparison group was 0.807. The mean difference, adjusting for baseline utility, was 0.0211, which also
TABLE 14 Use and costs of services and lost employment costs in months 0–6 following recruitment
Service
Comparison group (n = 37) Intervention group (n = 32)
n (%)
Mean (SD)
no. of contacts
Mean (SD)
cost (£) n (%)
Mean (SD)
no. of contacts
Mean (SD)
cost (£)
ED 14 (38) 2.9 (3.4) 53 (122) 17 (53) 1.7 (1.3) 44 (61)
Inpatient stays 5 (14) 11.6 (21.5) 633 (3320) 4 (13) 2.7 (2.1) 101 (384)
Clinical decision unit 5 (14) 1.8 (1.3) 144 (451) 11 (34) 1.1 (0.3) 222 (328)
Neurology outpatient 23 (62) 1.3 (0.6) 119 (114) 21 (66) 1.2 (0.4) 119 (102)
Other outpatient 17 (46) 2.2 (1.5) 147 (216) 15 (47) 1.5 (0.9) 106 (146)
Day care 2 (5) 2.5 (2.1) 20 (99) 3 (9) 1.0 (0.0) 14 (44)
GP contacts 27 (73) 3.6 (2.1) 71 (79) 25 (78) 3.6 (2.3) 105 (111)
Epilepsy nurse 2 (5) 1.0 (0.0) 2 (7) 27 (84) 1.6 (0.7) 51 (34)
Practice nurse 20 (54) 2.0 (2.1) .8 (14) 7 (22) 1.4 (0.5) 4 (8)
Physiotherapist 2 (5) 3.0 (1.4) 3 (16) 1 (3) 2.0 (–) 1 (6)
Social worker 0 (0) – 0 (0) 6 (19) 3.3 (4.3) 68 (238)
Medication 35 (95) – 260 (245) 31 (97) – 230 (204)
Total health- and
social-care cost
1461 (3643) 1065 (781)
Lost work days 3 (8) 4.7 (2.1) 30 (111) 6 (19) 4.8 (3.9) 73 (197)
Total cost 1492 (3648) 1138 (840)
Note: costs in UK£ 2010–11.
DOI: 10.3310/hsdr01090 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 9
53
© Queen's Printer and Controller of HMSO 2013. This work was produced by Ridsdale et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
was not statistically signiﬁcant (bootstrapped 95% CI −0.09 to 0.04). Based on these average costs and
QALY differences it can be seen that the intervention resulted in lower costs but fewer QALYs. The ICER
was £26,445 (−£558/−0.0211). This means that it costs an extra £26,445 to achieve 1 extra QALY if the
intervention is not used.
The cost-effectiveness plane (Figure 4) indicates that the most likely outcome is that the intervention
results in lower costs and a poorer outcome as measured by QALYs. There is a similar likelihood that the
intervention results in the best outcome (lower costs and more QALYs) and the worst outcome (higher
costs and fewer QALYs).
The CEACs (Figure 5) show that if a QALY is given a 0 value then the intervention is the most
cost-effective option. However, as a QALY receives a higher value the probability that the intervention is
cost-effective falls. NICE uses a threshold of £30,000 to determine the cost-effectiveness of services. At this
point the comparison condition is marginally more likely to be the most cost-effective option.
Summary
The 1-year costs before treatment allocation were on average £2355 per patient. Costs are signiﬁcantly
higher for black and minority ethic patients than for white British patients. The intervention reduced costs
but did not improve outcomes according to the EQ-5D, a generic measure of health status. The ICER for
standard care compared with the intervention was below the NICE threshold of £30,000 per QALY.
However, there is substantial variation around the cost and QALY estimates, and the overall conclusion is
that there is no evidence to suggest whether either the ENS intervention or TAU should be preferred.
TABLE 15 Use and costs of services and lost employment costs in months 7–12 following recruitment
Service
Comparison group (n = 37) Intervention group (n = 32)
n (%)
Mean (SD)
no. of contacts
Mean (SD)
cost (£) n (%)
Mean (SD)
no. of contacts
Mean (SD)
cost (£)
ED 14 (38) 4.0 (5.0) 74 (175) 10 (31) 2.2 (1.2) 34 (60)
Inpatient stays 8 (22) 3.5 (4.8) 306 (1036) 2 (6) 4.5 (2.1) 114 (473)
Clinical decision unit 9 (24) 2.3 (1.1) 337 (678) 6 (19) 2.0 (1.5) 222 (598)
Neurology outpatient 22 (59) 1.4 (0.7) 119 (124) 19 (59) 1.5 (0.6) 133 (131)
Other outpatient 5 (14) 2.0 (1.2) 40 (118) 14 (44) 1.4 (0.9) 92 (138)
Day care 1 (3) 1.0 (–) 4 (24) 6 (19) 2.0 (1.7) 55 (153)
GP contacts 22 (59) 3.6 (2.2) 92 (141) 23 (72) 4.1 (3.0) 140 (240)
Epilepsy nurse 3 (8) 1.3 (0.6) 2 (8) .8 (25) 1.5 (1.1) 11 (31)
Practice nurse 9 (24) 1.9 (1.6) 6 (25) 6 (19) 1.2 (0.4) 2 (5)
Physiotherapist 1 (3) 2.0 (–) 2 (9) 3 (9) 4.7 (1.5) 14 (51)
Social worker 1 (3) 1.0 (–) 3 (17) 3 (9) 2.0 (1.7) 36 (154)
Medication 35 (95) – 309 (299) 30 (94) – 234 (248)
Total health- and
social-care cost
1293 (1764) 1088 (944)
Lost work days 8 (22) 8.0 (9.7) 138 (434) 4 (13) 3.3 (2.2) 33 (103)
Total cost 1431 (1784) 1121 (927)
Note: costs in UK£ 2010–11.
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Chapter 5 Discussion
Principal ﬁndings
Our project makes an important contribution to a small body of research. Previous studies from the UK
and abroad describe attendance at EDs by PWE.32,52,104,126–128 These studies mainly focused only on the
appropriateness of ED attendance and lack of beneﬁt from EDs for PWE who attend in the context of
continuing care. No study had trialled an intervention for PWE that speciﬁcally aimed to reduce ED use, or
explored patients' own reasons for attending the ED. Our mixed-methods project provides evidence on
these issues and others. Our results provide new information on the frequency of ED use by PWE who
attended the ED, and their characteristics. It describes patients' views of their routine epilepsy care, what
ENS care added and who beneﬁted most, as well as quantitative outcomes. Finally we are able to
postulate potential targets that, if addressed, might reduce unnecessary attendance, provide efﬁciency
savings and improve patient self-management in the future.
Pattern of emergency department use by people with epilepsy
The ﬁndings from our baseline assessment showed that the pattern of ED use by people with established
epilepsy is different from that of general ED users, and that it is not homogeneous. In total, 39% of PWE
attended the ED only once within the previous year, and > 60% reattended. Speciﬁcally, 25% had visited
the ED on two occasions and the remaining 36% had attended on three or more occasions. This led to
about one-third (36%) of ED attendees accounting for almost three-quarters (72%) of all visits made by
the group.
Moore et al.36 examined reattendance at the ED by general ED users within a 12-month period and found
reattendance to be unusual – only 24% reattended, with most doing so on only one occasion. The pattern
of ED use reported by PWE is most similar to that of people with COPD, another chronic relapsing
condition.37 It does, however, exceed that reported for people with diabetes or asthma.37,38
In a US study, Bautista et al.129 reported that the health-related QoL of PWE who had attended the ED was
worse (weighted mean 27.8 on an epilepsy-related QoL instrument) than that of PWE who did not attend
(weighted mean 23.4). We used the same epilepsy-related QoL instrument and found the QoL reported by
our sample to be similarly low.
The characteristics of people with epilepsy who attend the
emergency department
The results from the baseline assessment also showed that PWE recruited from south London were
different from samples drawn from the wider epilepsy population. We found that all PWE attending the
ED reported having a seizure in the previous year whereas, in the general population, Moran et al.25 found
that 48% of PWE are seizure free. In total, 46% attending the ED reported from two to nine seizures and
42% reported ≥ 10 seizures in the previous year compared with 16% reporting from two to nine seizures
and 24% reporting ≥ 10 seizures in the previous year amongst PWE generally.
Anxiety was also more frequent amongst ED attendees. In total, 33% of ED attendees had ‘case’ levels of
anxiety, compared with 22% in the general population of PWE.108 However, ‘case’ levels of depression
were not raised compared with other epilepsy population samples.109
The ED attendees were also different in terms of the high proportion (68%) that felt stigmatised by their
epilepsy. It has been reported that those with newly diagnosed epilepsy are at particular risk of perceived
stigma.130 Using the same scale, Taylor et al.90 measured felt stigma amongst UK adults with newly
diagnosed epilepsy but nevertheless found that fewer patients (53%) reported stigma.
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Predictors of frequent emergency department use by people with epilepsy
Surprisingly, perhaps, we found that, in the previous 12 months, most of the PWE who we recruited from
the ED had received epilepsy outpatient care that was in line with national guidelines.50 This implies that
current guidelines for quality excellence do not meet the needs of some people with poorly controlled
epilepsy in terms of prevention of ED use. This is consistent with process evidence from a national audit
suggesting that ED use offers little added value to care.52 Using regression analysis we found that, in
descending order of importance, less knowledge, more felt stigma, poorer medication management and
greater seizure frequency predicted emergency visits before entering the study.
Twelve months after recruitment we found that the baseline variables identiﬁed as most predictive of
increased numbers of ED visits were, in descending order of importance, lower conﬁdence in managing
epilepsy (less mastery), higher number of prescribed AEDs, more felt stigma, higher number of previous ED
visits recorded at baseline, greater seizure frequency and higher levels of depression and anxiety. In
multivariate analyses, greater felt stigma and lower perceived conﬁdence in epilepsy management
remained signiﬁcantly predictive of ED visits at ﬁnal assessment.
The results from our cross-sectional analyses of factors associated with previous use at baseline, and of the
baseline factors that predicted ED use over follow-up, imply that these features require addressing through
the development of interventions to prevent unnecessary ED visits. A case can be made for how these
factors lead to ED use.
In terms of epilepsy knowledge, for example, it is possible that this mediates the relationship between
seizures and whether or not a patient attends the ED as a result. One means by which this might occur is
through the knowledge that a person has of ﬁrst aid for seizures. Some patients may attend because of a
lack of knowledge about what action to take. Most ED attendees do not require emergency treatment and
present after an uncomplicated seizure.24,131 Comparing knowledge of epilepsy scores among ED users
and the wider epilepsy population shows lower knowledge among ED users.110 For example, although
one-third of our sample (incorrectly) stated that it was always necessary to call a doctor or ambulance if a
person with epilepsy has a seizure, even if it occurred without complications, only 11% of a sample of the
wider epilepsy population gave this answer.132
Greater perceived stigma was also highly associated with ED use. This may be because patients who
perceive epilepsy to be a stigmatising condition ﬁnd it more difﬁcult to engage with treatment planning.
Buck et al.133 found that those who reported stigma were more likely to miss taking their AEDs.
Baker et al.130 found that patients who felt stigmatised were also more likely to have experienced a
seizure injury.
To a lesser extent, poorer medication self-management and increased seizure frequency also had
independent roles in predicting ED use. This concurs with the results of previous studies. Poor adherence
to AEDs is known to be associated with an increased number of ED visits, and the risk of seizure-related
injuries is 21% higher during non-adherent periods.134,135 The modest role of seizure frequency indicates
that ED use is not simply a marker of seizure control.
Patients’ explanations for attending an emergency department for epilepsy
This was a mixed-methods study including quantitative, qualitative and health economic analyses.
From the perspective of PWE, the results of the study will be best represented by the stream of the study
that collected and analysed the views of users. We found that users viewed their need to use the ED as
contextual. It depended partly on whether their seizure occurred at home or in a public space, and partly
on the knowledge, experience and conﬁdence of those nearby of what to do. Other triggers were fear of
death among PWE and others.
People with epilepsy frequently cannot make decisions themselves when they have a seizure, as they are
unconscious or confused. From the patients' perspective, use of emergency medical services was regarded
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as appropriate, particularly when they are away from home and when they do not have someone who
knows about seizure management nearby.
Our results concord with those of previous studies. An internet survey of public attitudes to witnessing a
seizure found that two-thirds of respondents would promptly contact the emergency medical services.136
Our participants said that they would expect this action to be taken by members of the public.
Fear of death or ‘death anxiety’ has also been described in a quantitative study of patients attending
outpatient neurology clinics.137 It was found to be associated with generalised epilepsy, higher anxiety
scores and lower levels of education. We did not measure ‘death anxiety’ using quantitative methods but
the cohort group in which this qualitative study was nested did have higher anxiety scores and a lower
knowledge of epilepsy than PWE in other studies of the general epilepsy population.
Health economics of emergency department use
Emergency department visits at baseline accounted for 43% of total service costs, with medication
accounting for 19% of total service costs. The regression of service costs on patient characteristics revealed
that black and ethnic minority patients had costs that were higher on average by £733 (95% CI £401 to
£1065). Total costs were also higher (by £714 on average) for black and ethnic minority patients (95% CI
£384 to £1045). As part of the capacity development associated with this project (see Appendix 5), one of
our MSc students (Fazia Sheikh, 2012) has carried out a literature review of the sociocultural perspectives
of black and ethnic minority populations living with epilepsy. She found some evidence from the UK that
South Asians hold alternative hypotheses about the cause of epilepsy and potential treatments, which may
be important for clinicians to be aware of and address.60 There is no evidence to date on the views of PWE
from black ethnic minority communities, which compose 40–50% of the population of south London.
However, there is evidence from research in West Africa, from where many of the black Africans originate,
of PWE suffering discrimination, stigmatisation and social deprivation, and of women in particular suffering
physical and sexual abuse because of their epilepsy.59,138 This might also be experienced to a lesser degree
by black ethnic minority PWE living in the UK, as a consequence of past experience, or through the
inﬂuence of family or friends. This could be an important barrier to black ethnic minority PWE acquiring
the knowledge and skills necessary for self-management. If this were so, these PWE might require a
different and stepped-up intervention to address stigma for them to engage more fully with learning
self-management skills.
Effect of the epilepsy nurse specialist-led self-management intervention on
subsequent emergency department visits
Health service planners need interventions to reduce unnecessary emergency hospital visits by people with
established epilepsy. In this study we have completed the ﬁrst trial of an intervention to achieve this. We
compared the effectiveness of a self-management intervention delivered by an ENS with the effectiveness
of TAU alone for reducing subsequent ED visits. No statistically signiﬁcant beneﬁt was found in terms of
reducing subsequent visits to the ED, nor was there any improvement in patient well-being.
Recruitment for our study was slower than anticipated and the trial stopped with 69 participants instead of
the planned-for 120. This is reﬂected in wider CIs for the key estimates and consequent ambiguity in some
conclusions. The results from our adjusted analyses are, nevertheless, evidence against the possibility of a
large (50%) reduction in number of ED visits.
Why was the intervention not effective? First, although previous evidence had suggested that such
interventions could reduce the frequency of ED visits,80–82 this came from studies using weak
methodologies. This included studies comparing ED visits in patients before and after receiving the
intervention, and which did not have a TAU comparison group. All reductions in the frequency of ED visits
were therefore attributed to the effect of the intervention. However, the results from our baseline
assessment show that, even without the speciﬁc support of a nurse, 40% of epilepsy attendees do not
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revisit an ED in the subsequent 12 months. We included a TAU comparison group to allow for this.
The increased methodological rigour of our study may explain why our results are different.
Second, it is also perhaps not surprising in the context of a trial in a deprived area with a group of
participants who had more seizures, greater levels of anxiety, a lower knowledge of epilepsy and its
management and greater perceived epilepsy-related stigma than the average PWE, that two visits with an
ENS lasting in total about 90 minutes failed to change the frequency of ED attendance or impact on
secondary outcomes. More intensive interventions are used to improve self-management skills in those
with other chronic, relapsing conditions. In type 1 diabetes, for example, a 5-day course is required to
improve functioning (glycaemic control) and QoL.139
Finally, the intervention was not designed to redress all of the factors found to be predictive subsequently,
as they were not known. Even if they had been known, the size of the intervention was limited as NIHR
terms and conditions required it to be self-funded by the hospital trust as an additional treatment cost.
It was probably too dilute.
Cost-effectiveness of the epilepsy nurse specialist-led
self-management intervention
The health economic evaluation provided a different perspective on the utility of the intervention.
Speciﬁcally, during the ﬁrst 6 months of the follow-up period, more participants in the intervention group
had ED contacts than participants in the comparison group, but for those in the intervention group who
did have contacts, the number of contacts was fewer and this resulted in lower ED costs for the
intervention group. A similar number in each trial group had inpatient episodes, but the duration of the
stays were longer for the comparison group and hence the costs of inpatient care were 527% higher than
for the intervention group. Costs of other services were similar, and total service costs for the intervention
group were 27% lower than those for the comparison group.
In the 6 months before the 12-month follow-up there was little difference in ED use and costs but there
remained a difference in inpatient costs, which were lower for the intervention group. Total service costs
for the intervention group were 16% lower than for the comparison group. The mean total service costs
over the entire follow-up period were £2202 for the intervention group and £2948 for the comparison
group. The difference in mean costs, adjusted for baseline costs, was £558. This was not statistically
signiﬁcant (bootstrapped 95% CI −£2409 to £648). We did not measure seizure severity at the 12-month
follow-up and it is possible that the intervention group had a lower seizure severity.
In the economic evaluation the QALY gain over the follow-up period was 0.786 for the intervention group
compared with 0.807 for the comparison group. This result was unexpected and runs counter to the
ﬁnding that the more detailed and speciﬁc epilepsy QoL measure did not show a difference between the
intervention and comparison groups. We would tend to give more credibility to the speciﬁc epilepsy QoL
measure, which covers a longer period of a month rather than a day.
Patients’ views of the epilepsy nurse specialist-led self-management
intervention and how it compared with usual care
Qualitative evaluation of the ENS intervention, undertaken 1 year after the trial started, added to an
understanding of why a lack of effect occurred in terms of a decline in frequency of ED visits after the
intervention. About 40% of PWE used the ED only once in the year and felt that they did not need
additional input to their self-management. The number of areas in which our participants perceived a
beneﬁt to have occurred from the intervention, and the extent of the beneﬁt, were, however, associated
with the degree to which the participants had previously visited the ED. Those who had used the ED the
most tended to report the most beneﬁt from the intervention. Our results suggest that offering some form
of additonal advice and support only to those who attend the ED on more than one occassion in the
previous year is perceived as helpful by PWE.
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The intervention was almost universally valued by our participants. This ﬁnding counters speculation that
PWE who have attended the ED may not accept or engage with additional treatment.41,119 The main
reason given for valuing the intervention was that it redressed limitations perceived in their usual epilepsy
care. In particular, they felt that the content of the intervention sessions was tailored to their inividual
needs, sessions were less time pressured and the ENSs were more considerate of, and attentive to, the
broader aspects of living with epilespsy.
The areas in which participants reported beneﬁts to have occurred – in particular, improved emotional
well-being (including reduced perceived stigmatisation), better medication management skills and
greater conﬁdence in managing seizures – have been suggested as being causally related to ED
visits by PWE.134,135,140–144
As part of a mission for capacity building, we supervised four King's College London MSc Neuroscience
students to undertake successful dissertations on epilepsy during the study (see Appendix 5). This
contributed to our ﬁndings and complemented them. A qualitative study undertaken by one MSc student
who was an ambulance clinician focused on the views of ambulance clinicians about their decision-making
when called to PWE.145 Participants reported that their previous experience was important, more so than
training, in determining their conﬁdence to manage PWE. But they added that training and guidelines
were insufﬁcient and that sometimes decisions were made to avoid a perceived threat of litigation.
Ambulance clinicians reported that lack of someone to contact, and of information on patients, were
important and could lead to PWE being transported to the ED unnecessarily.145
Strengths and weaknesses of the project
As noted, our project makes an important contribution to a small body of research. However, our results
should be interpreted in light of some limitations. In the following sections we describe the respective
strengths and weaknesses of each of the main components of our project.
Quantitative component
Study 1: an evaluation of a group of people attending the emergency
department for epilepsy, their use of emergency services and their
psychological state, knowledge of epilepsy, perception of stigma, quality
of life and needs
To evaluate the characteristics and needs of PWE attending the ED and their pattern of ED use,
participants' responses to the questionnaires administered at the trial's baseline assessment – which
occurred before any differences in care were implemented – were described and compared with ﬁndings
from the literature in those from the wider epilepsy population.
The ﬁrst potential limitation of this component of the project is that the participant acceptance rate into
the study was low. Of those we invited, 27% agreed to participate. Low acceptance raises the possibility
that those who agreed to participate in our study may not be representative of PWE who attend the ED,
limiting the generalisability of the results. Information on the non-recruited patients' epilepsy was limited
to their ED records, as wider access to their medical records was not ethically permissible. This meant that
our comparison of participants and non-participants was restricted to age, gender, deprivation status,
ethnicity and the clinical urgency of their ED presentation.105 We also extracted information recorded by
their primary care practices for the 2009–10 QOF85 to compare their epilepsy care generally. According to
these measures we found that those who agreed to participate were representative of PWE attending the
ED from which they were drawn, with one signiﬁcant difference being that fewer eligible people of
non-white ethnicity were recruited. It is well known that recruiting people from minority groups, as well as
women and those of certain ages, is difﬁcult and under-representation is common.146
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To help identify the determinants of ED use, in this study we examined the association between patients'
characteristics and the number of ED visits that they reported having made over the previous 12 months.
A limitation of this part of our study is that the cross-sectional design of the analysis means that
conclusions cannot be made on the basis of the results about the direction of the relationship between the
factors in our regression model. The directionality may be the other way around.
A third potential limitation is that, as the baseline assessment was part of our trial to compare the effect of
the ENS-led self-management intervention with the effect of TAU, those who had recently seen an ENS
and those referred to neurology by the ED were excluded from the study. This could have led to the
exclusion of certain categories of patients, which limits the generalisability of our results to all PWE who
attend the ED. However, the number excluded on the basis of these criteria was small (amounting to 12%
of all exclusions).
Fourth, we used self-report data. This is common and accords well with concepts such as QoL, which
emphasise the experience of the individual. However, the reliance on patient reports of seizure frequency
introduces the possibility of bias. Although there is limited consensus on how else to measure seizures over
a sustained period in community studies, many patients are not aware of, or are amnesic for, a proportion
of seizures.147 We also relied on patients to self-report their ED use as there is no national record of an
individual's ED attendances, but PWE have been found to be reasonably accurate in recalling use of other
health-care services, particularly hospital-based services, over the previous year.24,32
Although the UK NHS differs from national health services in other countries in some speciﬁcs, it is publicly
funded like those in the majority of Western countries.148 A strength of our study is therefore that our
results may be readily generalisable to many other countries. We also recruited from an urban, ethnically
diverse population with a high degree of deprivation. Although ﬁndings may be less generalisable to rural
and less deprived areas,149 the potential similarity of our multiethnic population to populations in
metropolitan areas in other countries may mean that our evidence is generalisable internationally.
Study 2: quantitative evidence from a comparison of two groups, one
receiving usual care and the other receiving an epilepsy nurse
specialist-led intervention
The ﬁrst limitation of our comparison of the two treatment groups was that treatment allocation was not
randomised but rather was based on the site from which participants were recruited. Randomised studies
produce more accurate estimates of treatment effect.150 The advantage of randomisation is that, when
undertaken properly, it reduces the potential for bias in the allocation of patients to different treatments
and, on average, the groups are balanced on known and unknown covariates.151 It is possible that
unknown baseline differences existed between our treatment groups and these may have confounded the
results and reduced the accuracy of our treatment effect estimate.
In considering how accurate our treatment effect estimate is we sought to minimise the likelihood of
group differences by restricting recruitment to PWE from similar hospitals and similar areas. We also
endeavoured to capture group differences by using a wide selection of baseline measures, with adjustment
for differences detected. We also used prospective recruitment methods, which can make a
non-randomised trial's estimate of effect similar to that of a randomised trial.150
A second potential limitation to the study is that the researcher administering the assessments was not
blind to the treatment allocation of the participants. This may have inﬂuenced the assessments
in some way, even though the same scoring procedures were followed for each participant, and the
outcome negative.
Finally, as already noted, recruitment was slower than anticipated and the trial stopped with
69 participants instead of the planned-for 120. This is reﬂected in wider CIs for the key estimates, and
consequent loss of power, with ambiguity in some conclusions. The reason why the intended sample size
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was not achieved was because the 27% participant acceptance rate into the trial was lower than the rate
of 50% that we had anticipated. It is now apparent from studies in the wider literature that low
acceptance rates are common in studies on ED attendees with long-term conditions and in trials in which
serial assessment is required.139,152 When planning our project this information was not available and no
previous studies had exclusively recruited PWE from EDs. In previous epilepsy nurse studies our group had
obtained 80–84% recruitment rates.54,63 Because studies had not been conducted in socially deprived
areas or speciﬁcally with those with poor epilepsy control, we had considered an adjusted estimate of
50% to be reasonable. It became apparent subsequently that even this conservative estimate was
too optimistic.
Future studies that intend to recruit PWE from EDs should factor in low uptake rates and implement
evidence-based strategies to maximise recruitment. For example, we offered all participants a £20
shopping voucher as evidence suggests that ﬁnancial incentives are generally found to facilitate
recruitment.153 Participant acceptance may be further maximised in future ED studies if a research worker
is available to recruit participants directly from the ED. We did not have the resources to do this. We were
funded for one research worker whereas patients attend the ED 24 hours a day, 7 days a week. AN
needed to assess participants in the community at baseline and follow-up and was responsible for all of
the project's administrative tasks. We therefore posted an invitation letter to those patients who were
eligible, asking them to express their interest using a response slip and Freepost envelope. A potential
limitation of such an approach is that, as a research team, we did not have an established relationship
with the patients. This relationship and trust is what many potential participants depend on when
considering participation in a trial.154 Research worker(s) recruiting directly from the ED could more readily
align themselves with the patients' treatment teams. The feasibility of recruiting PWE directly from the ED
would require clariﬁcation. For example, patients may often be in a postictal state and, also, a stay in the
ED is typically far shorter than a stay on a hospital ward.
It is also important to note that our study design obliged us to exclude a high number of patients on the
basis of non-residence within one of the London boroughs served by the hospitals from which we
recruited. Speciﬁcally, of the 628 patients we excluded, in 56% of cases this was because they did not live
in one of the three boroughs directly served by the EDs. There were two reasons for excluding such
patients. The ﬁrst was to promote the similarity of the participants who compose the treatment arms in
this non-randomised trial by ensuring that they came from areas with comparable levels of epilepsy
control, social deprivation and ethnic diversity. The second reason was more pragmatic as many people
attending inner London hospitals, such as STH, which is located next to a major transport hub (i.e. London
Waterloo railway station), do not live in London. Recruiting such people would have potentially resulted in
a lower rate of attendance at the intervention sessions and potentially a higher loss of participants to
follow-up. A lower rate of exclusion would likely occur if future studies recruit from a less
metropolitan area.
At follow-up we retained 81% of the participants who were recruited into our trial. This rate of retention
is favourable when compared with that achieved by many previous epilepsy trials.9,10,155 It is important to
note, however, that the dropout rate was higher in the intervention group and there was some evidence
that it was those participants who felt most stigmatised by their epilepsy that were more likely to be lost.
As loss to follow-up can introduce bias and mean reduced statistical power,156 future trials with PWE
recruited from EDs should consider implementing strategies to maximise the retention of intervention
participants. If a future trial were designed to test an intervention that is delivered in a location outside of
the patient's home, one strategy to increase retention might be to offer participants free taxi travel to the
location of the intervention. We suggest this because a difference between being in the intervention group
and being in the comparison group in our study was that intervention group participants were requested
to visit a hospital clinic on several occasions to receive the ENS-led self-management intervention.
According to UK regulations a person who has suffered an epileptic seizure cannot legally drive for at least
1 year. This means that people with poorly controlled epilepsy often depend on public transport. Recent
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evidence shows, however, that those PWE who feel most stigmatised by their condition are more likely to
be worried about the possibility of having a seizure, but at the same time have a smaller network of
friends and family to support them, such as to accompany them on trips outside of the house in case a
seizure occurs.157,158 This might explain why participants in our study's intervention group who felt most
stigmatised were less willing or able to stay in the study. Providing such people with the possibility of free
travel by taxi to the intervention might lead to more of them staying in the study.
Qualitative component
Study 3: qualitative study of patients' views, experiences of the service and
reasons for attending the emergency department
For this component of the project we interviewed 16 PWE from the intervention group and three from the
TAU group after they had completed their ﬁnal assessment as part of our trial. Participants for the trial
were identiﬁed and recruited because they had experienced a seizure and had attended an ED. In the
wider epilepsy population, not all people who have seizures attend an ED. Epidemiological data, for
example, show that approximately half of PWE in the UK experience seizures each year,25 but only
13–18% attend an ED annually.24,32 Therefore, a potential limitation to this qualitative study, which aimed
to explore the reasons for ED attendance, is that we did not interview PWE who had experienced seizures
but who did not attend an ED. Also, patients were interviewed just over a year after the ED visit that
precipitated their initial recruitment. Nevertheless, most patients had experienced more seizures than ED
attendances and they were able to describe episodes that led to the emergency services being called, as
well as episodes when ED attendance was avoided.
A second potential limitation is that only the ﬁrst 24 participants to complete the trial were invited to be
interviewed. These PWE do not necessarily represent the whole sample, the population of south London
or, indeed, the UK population. It is possible that a different rationale for calling the emergency services
might be used in rural areas, for example, where distance to the hospital requires more travel.
Study 4: patients' views after 1 year of follow-up of the extent to which the
epilepsy nurse specialist-led self-management intervention met their needs
As noted for the previous qualitative study, we invited to interview the ﬁrst 24 participants to complete the
ﬁnal trial assessment. Sixteen of these participants were from the intervention arm and they were asked
about their views of the intervention. Because the ENSs delivering the intervention had not previously
delivered self-management support to those who had attended the ED, it is possible that their ability to
deliver the intervention was greater for later participants who were not interviewed by us. If this was the
case, a limitation of our study is that its results may present a less optimistic view of the potential beneﬁts
of the intervention.
A second potential limitation is that the beneﬁts that participants described could have been inﬂuenced by
the skills of the particular nurses who delivered the intervention. It could be that different ﬁndings would
emerge if different people delivered the intervention. This is not a feature unique to our intervention but is
common to most psychosocial interventions, including those that are already part of mainstream health
care, such as cognitive–behaviour therapy.159 To promote replication of the intervention and its beneﬁts,
we have fully described it and the characteristics of those delivering it (see Chapter 2). Also, two ENSs
delivered the intervention to limit the inﬂuence of an individual therapist.
Finally, in considering the generalisability of our results, our trial participants were recruited from a
deprived urban UK population. Some of the difﬁculties that our participants reported with their usual
epilepsy care and the beneﬁts derived from the intervention may result from the views of people from
such areas. However, similar limitations to usual care have been reported by PWE from other countries
and by PWE from different areas in the UK.160–162
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Health economics component
Study 5: an economic evaluation of the previous service use reported by people
attending the emergency department for epilepsy and of the cost-effectiveness
of the epilepsy nurse specialist-led self-management intervention
The reliance on patient self-report of service use is a potential limitation of the economic evaluation,
although a number of previous studies have shown this to be a reasonable method to use.163,164
The strengths of the study are the use of QALYs as an outcome measure and the breadth of service
use included.
Future research: implications
1. Testing workshops on seizure management for PWE and their signiﬁcant others.
2. Testing self-management education programmes for PWE.
3. Exploring the perception of stigma and self-management.
4. Exploring the perception of stigma and self-management among ethnic minorities.
5. Evaluation of the needs of PWE who attend EDs in different areas of the UK.
6. Development of interventions to manage anxiety and death anxiety for PWE and their carers.
7. Risk factors for ED attendance and risk of death in epilepsy: mortality prevention.
Priority 1: testing workshops on seizure management for people with
epilepsy and their significant others
As a consequence of our exploratory interviews, we believe that all district hospitals might in the future
develop and provide regular workshops, for example monthly, on seizure management for PWE, who
would be invited to come together with their signiﬁcant others. These workshops would need to be
provided repeatedly to enable PWE to bring different members of their family, a partner or new partner,
friends as they become closer and work colleagues whenever they change their employment.
Practical training could be provided on triggers to seizures and how to manage them, as well as on
prevention of injury, together with time provided for PWE and their signiﬁcant others to discuss fears of
death. This initiative might be led by ENSs in collaboration with clinicians in emergency medical services.
This might be evaluated most rigorously by means of a randomised controlled trial. Mixed methods
including a qualitative approach to evaluate users' perceptions of how to present the intervention to other
potential users, how users and NHS providers should invite participation from signiﬁcant others, and the
timing, duration and content of the intervention should be considered to optimise participation as well
as any beneﬁts of the intervention. We have demonstrated the high cost of ED attendance with few
beneﬁts. The trial should be powered to measure potential efﬁciency savings by means of robust health
economic evaluation.
Priority 2: testing self-management education programmes for people
with epilepsy
In the UK, self-management programmes have been tested and adopted for other chronic conditions
(e.g. diabetes: DAFNE,14 DESMOND,15 X-PERT;16 arthritis17,18). Given the perceived lack of information for
PWE, their perception of stigma, their anxiety and their lack of conﬁdence in managing their condition, we
believe that there is scope to evaluate longer structured interventions designed to meet these needs. One
option is a self-management learning programme for PWE, rather like the 1-week programme that has
already been trialled for diabetes and rolled out in the NHS.139
We have been funded by the NIHR Health Technology Assessment programme (ref. 09/165/01) to modify
and test a 2-day course developed in Germany for PWE for the NHS context.74 This is targeted speciﬁcally
for people with chronic poorly controlled epilepsy.
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From our research evidence and that of others, it is likely that, as in other conditions, for example diabetes,
all PWE would beneﬁt from a self-education programme from the time of ﬁrst diagnosis. We have
demonstrated a high level of variation in people's knowledge of epilepsy, which correlates with their
general education. For some people step-up learning and support strategies will be required. This may be
particularly important in areas of high social deprivation and for ethnic minority groups to tailor learning
speciﬁcally. We have highlighted the higher cost of health services for our participants of black ethnicity.
If more investment, linked to their speciﬁc needs, is effective in improving self-management, there is scope
for greater efﬁciency savings as well as patient beneﬁts.
Priority 3: exploring the perception of stigma and self-management
Our evidence suggests that the perception of stigma may be a particularly important mediator between
seizures and ED use. Lack of acceptance of their condition by PWE (or their signiﬁcant others) may prevent
PWE from fully accepting their condition and engaging with health professionals to acquire the skills to
manage it in the long term. It is currently unknown what support should be offered to PWE who
experience felt stigma. When there is stigma and denial, as occurs in other long-term conditions such as
addiction, motivational interviewing has been recommended to increase clients' sense of ownership and
self-efﬁcacy. It might be feasible to help PWE who also feel stigmatised to engage more fully with
self-management by developing a purpose-designed motivational interviewing approach and testing it by
means of a randomised control trial.
Priority 4: exploring the perception of stigma and self-management among
ethnic minorities
We believe that we have identiﬁed a need for more research on the views of black ethnic minority people
about epilepsy and self-management. It seems likely from the literature that they are more at risk of felt
stigma and this may be a consequence of the beliefs and behaviours held by signiﬁcant others. We are
currently exploring the views of people from this population.
We have highlighted the signiﬁcantly higher costs of health services incurred by those of black ethnicity.
If more investment, linked to speciﬁc concerns, is effective in improving self-management, there is scope
for greater efﬁciency savings as well as patient beneﬁts. In a time of unprecedented international
migration, we propose that more qualitative research might be carried out on the speciﬁc attitudes, beliefs
and needs of PWE from ethnic minorities, particularly when addressing them has the potential to reduce
health inequalities.
Priority 5: evaluation of the needs of people with epilepsy who attend
emergency departments in different areas of the UK
We planned our study in an area of social deprivation in the inner city and completed it before the NASH
was published.165 The NASH has highlighted wide variations in standards of care, with, in particular, poor
follow-up, communication and services for PWE attending EDs across the UK. NASH calls for more
in-depth research and there is some momentum for hospitals to address the problems identiﬁed across
the NHS.
Our ﬁndings will generalise best to similar metropolitan populations in the UK and abroad. We do not
know how people behave in rural areas, where, for example, a trip to the ED may take much longer.
Because of this we plan to replicate the ﬁrst stage of the study, describing quantitatively the characteristics
of PWE who attend an ED in a rural area. This is in collaboration with local physician scientists and will be
funded by Epilepsy Bereaved. We believe that, although there has been some quantitative research carried
out on PWE attending EDs, more can be learned by using mixed methods, including in-depth qualitative
and economic research. This requires more funding but may result in efﬁciency saving in the longer term,
as well as improvement in patient outcomes.
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Priority 6: development of interventions to manage anxiety and death
anxiety for people with epilepsy and their carers
There remains scope for developing and testing other interventions. Speciﬁcally, interventions are needed
to identify and manage anxiety and death anxiety, for example, using cognitive–behavioural therapy.
The way in which risk is communicated to patients has been researched in depth in dealing with, for
example, genetic conditions.166 PWE are at higher risk of death. In addition, sudden loss of consciousness
can evoke fear of imminent death.68–71 In this context more research is needed to develop and test ways to
explain risk of death and manage death anxiety among PWE and their signiﬁcant others.
Priority 7: risk factors for emergency department attendance and risk of
death in epilepsy: mortality prevention
At a time of recession and public spending restraint, research can be targeted towards efﬁciency savings,
including prevention of recurrent and clinically unnecessary ED use. We have ourselves focused to some
extent on this. However, during the study we identiﬁed complex factors that predict ED use. At the same
time, deaths that are amenable to medical intervention by identifying and treating risk factors such as
hypertension, or preventable by individual behaviour change or public health measures such as smoking
cessation/prevention have also been targeted in the UK's NHS policies.167 Mortality from all causes in the
general population of England and Wales declined by 16% between 1993 and 2005; in contrast, mortality
with epilepsy recorded as an underlying cause increased by 31% in males and 39% in females during
this period.168
Epilepsy is ranked as the ﬁfth highest amenable cause of years of life lost before the age of 75 years for
males and the eighth highest for females.169 A cohort study of PWE dying over an 8-year period reported
that 30% of them died of accidents (mostly drowning and burns), 23% died suddenly, 16% died in status
epilepticus and 14% committed suicide.170 An audit of sudden epilepsy-related deaths in the UK found a
lack of communication between professionals and with families and estimated that 40% of adult and
60% of child deaths were potentially avoidable through improved care.171 The 2012 UK NASH52 found
that advice was not typically given to patients who had attended an ED or their carers on seizure
management, nor was there referral at the time for assessment by the neurology team or for follow-up by
a relevant specialist.
Large-scale epidemiological work might show that frequent use of EDs is a proxy for, or marker of, greater
need and risk of death in epilepsy. Our study was small but one out of 85 recruited participants died in the
follow-up year. At the same time our research group undertook a case–control study to quantify risks of
death in epilepsy, based on the UK General Practice Research Database, which included 1.5 million
registered medical patients.22 The risk factors for mortality identiﬁed were recorded alcohol problems, a
‘missed’ prescription for anticonvulsant drugs, a history of injuries, treatment for depression and one or
more seizures in the past year. Some of the risk factors identiﬁed for death in epilepsy are also predictors
of frequent ED use. In the current study people with primarily alcohol problems were excluded as a
different nurse specialist service is responsible for their management at hospital. However, the NASH
study52 found that epilepsy with alcohol overuse was a frequent correlate of ED attendance. In the current
study predictors of frequent attendance were lower conﬁdence in managing epilepsy, a higher number of
prescribed AEDs, more felt stigma, a higher number of baseline ED visits, greater seizure frequency and
higher levels of depression and anxiety.
People with long-term neurological conditions have received continuing and linked-up care. GPs have
acknowledged a lack of competence and conﬁdence in epilepsy management.172 Until recently there was
no funding for epilepsy care in general practice to support systematic identiﬁcation and monitoring.173 We
believe that there is a need for large-scale programme research to identify risk factors and service use
across primary and secondary care, which may link up processes to the goal of reducing avoidable death.
This will include large-scale epidemiological work linking data sets, the development and testing of
interventions, and mixed quantitative, qualitative and economic evaluation.
DOI: 10.3310/hsdr01090 HEALTH SERVICES AND DELIVERY RESEARCH 2013 VOL. 1 NO. 9
67
© Queen's Printer and Controller of HMSO 2013. This work was produced by Ridsdale et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.

Chapter 6 Conclusions
Six out of seven hospital admissions for PWE are unplanned and are the result of them attending anED.47 One in ﬁve PWE attend an ED each year.24 We have presented here the ﬁrst in-depth study of the
characteristics and needs of PWE attending an ED and our study was exploratory in this context. We found
that > 60% of PWE who do come to an ED reattend in the same year and one-third attend three or more
times. The average total health- and social-care cost of ED attendees is £2210 per year, and 50% of this is
consumed by ED attendance and the hospital use that ensues. Evidence from the 2012 UK-wide NASH52
indicates that two-thirds of hospital emergency attendances are not clinically necessary and result in no
beneﬁt for the ongoing care and self-management of PWE.
Nonetheless, we found that PWE who do attend the ED report lower conﬁdence in managing epilepsy
(less mastery), a higher number of prescribed AEDs, more felt stigma, a higher number of baseline ED
visits, greater seizure frequency and higher levels of depression and anxiety. The perception of feeling
stigmatised and having less mastery were consistently predictive of frequent attendance at the ED,
suggesting that these people do have unmet needs. On interview, people with recurrent seizures were
able to describe why a particular seizure led to use of hospital services. They reported that they did not
always have someone nearby with sufﬁcient knowledge, experience or conﬁdence who could help them,
be it a family member, friend or work colleague. Some participants reported that they or a signiﬁcant
other were inﬂuenced by fear of death, and indeed one participant did die during the trial's 12-month
follow-up period.
The study was designed as a ‘natural’ comparison between a hospital that had two ENSs who could offer
two appointments to people who attended the ED and two hospitals that did not have any ENSs. The
main outcome measure was frequency of use of the ED and this did not change after the intervention.
However, duration of hospital stay following ED attendance was reduced for the group who received the
ENS-led self-management intervention. After adjusting for differences at baseline, the mean total service
cost over the entire follow-up period was £2948 for the comparison group and £2202 for the intervention
group. This was not statistically signiﬁcantly different; however, the study was small and underpowered to
show this.
Participants who at baseline reported having used the ED the most, perceived the most, beneﬁt from the
intervention on interview. They described the intervention as improving on their usual care by providing
information about managing their epilepsy and an opportunity to talk about their feelings. Beneﬁts that
participants reported included improved emotional well-being, improved conﬁdence in managing seizures
and improved medication adherence.
We did not know patients' perceptions of the reasons for hospital attendance at the outset. If we had
known we might have targeted the intervention towards increasing the knowledge, conﬁdence and skills
of family, friends and colleagues, in addition to those of PWE. Equally, the issues of stigma and death
anxiety, highlighted by the study of ED attendees, were not known and might require a step-up
intervention of longer duration.
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Appendix 1 Protocol
Version 4
Can a nurse-led self-management intervention reduce
attendance at A&E and promote wellbeing for people with
severe epilepsy?
The objective of this study is to test whether nurse led rehabilitation is more cost effective in meeting the
needs of people with poorly controlled epilepsy as compared to usual care and is an evaluation of clinical
effectiveness and cost effectiveness of services at two hospitals.
85 patients with acute epilepsy attacks will be recruited from (A) King's College Hospital and (B) Guy's and
St Thomas' Foundation Trust and University Hospital Lewisham (approximately 50% from site A and 50%
from sites B).
Inclusion criteria
l Aged 18 and over.
l Have epilepsy that has been diagnosed and treated with medication.
l Be able to communicate in English sufﬁciently to complete questionnaires.
l Be resident and registered with a GP in one of the three surrounding PCTs: Southwark, Lambeth and
Lewisham.
Exclusion criteria
l Having no diagnosis; new epilepsy leads to a referral to a neurologist.
l Having already seen a specialist nurse for epilepsy in the prior year.
l Alcohol or other substance misuse.
l Other severe medical illness, such as psychosis or terminal cancer.
Patients attending the A&E sites due to epilepsy will be identiﬁed by weekly computerised searches of the
hospital admission data-bases and with the assistance of the consultants Drs. Ed Glucksman, Tunji Lasoye
and Nadeem Nayeem from King's College Hospital, Guys and St. Thomas' Hospital and University Hospital
Lewisham A&E departments. The experienced research associate working on this project will send an
invitation letter to those patients who have been identiﬁed as suitable. Attached to this letter will be the
study information letter and an ‘expression of interest’ reply slip and pre-paid return envelope. The
research associate will then explain the study in depth with any patients who express an interest. Written
consent to participate will be taken by the research associate.
The Research Associate will coordinate the baseline and the follow-up data collection to achieve
participation and collaboration throughout. Two competent and qualiﬁed nurses with a special interest in
epilepsy will work with patients from the intervention group in order that they may be referred to specialist
rehabilitation workers from a multidisciplinary team.
Baseline variables and questionnaires will be administered to all patients:
l Age
l Gender
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l Racial/ethnic group
l Economic (Index of Multiple Deprivation for postcode) [1]
l Quality of routine medical care (epilepsy components of Quality Outcomes Framework - QOF) in
particular for general practices [2]
l Liverpool Quality of life questionnaire [3]
l A knowledge of epilepsy questionnaire [4]
l Psychological distress measured using the Hospital Anxiety and Depression Scale (HADS) [5], and
Stigma Scale [6].
l Satisfaction with information on medications (SIMS) [7].
l Medication management skills [8].
l Mastery/conﬁdence in managing epilepsy [9]
l Quality of life in epilepsy measured by the 10-item Quality of Life in Epilepsy questionnaire
QUOLIE-10 [10].
l Quality-adjusted life years (QALYs) will be measured with the EQ-5D [11].
l General and epilepsy-related service use in the past 6 or 12 months measured using a version of the
Client Services Receipt Inventory (CSRI), modiﬁed for use in epilepsy [12].
Intervention Group
An appointment with a nurse with special interest in epilepsy will be offered after the patent has been
discharged following an A&E attendance, including access to other members of the multidisciplinary team,
and an expert-user group, in addition to usual medical care. The nurse will assess the patient identifying
the nature and extent of their problems and the factors relevant to their resolution. Family and or carers
will be included, provided the patient agrees. The nurse will help the patient set goals, provide information
and support. They will also be offered speciﬁc treatments for example to social services, psychology,
neurology, occupational therapy, an employment ofﬁcer, the learning disability team. Further input will be
as judged by nurse and client, but will include at least one follow-up appointment three months later.
The duration of the intervention will be 3–6 months.
Comparison Group
The comparison group will be offered the usual medical care where no special epilepsy nurse is available
and will receive usual medical care.
The baseline questionnaires will be repeated at 6 and 12 month follow up and additional measures taken:
l Primary outcome will be re-attendance at A&E.
l Secondary outcome with be unplanned readmissions to hospital for epilepsy.
l A cost analysis of the above.
l Seizure frequency and severity, the impact of epilepsy, perceived mastery, and medication
management skills.
Nested Qualitative interview
A purposeful sample of those respondents' with a range of scores on the Seizure Severity Scale will be
interviewed at either their home or a mutually convenient public place. Questions will cover:
l Reasons for attendance at A&E and effects of the circumstance in which the seizure occurred and
carers concerns and decision making.
l Patients' views and satisfaction with the ways in which these interventions met or failed to meet
their needs.
l Speciﬁc beneﬁts and limitations of the intervention examined in detail with particular reference to
patients' perceptions of epilepsy.
l Views of and adherence of patients' epilepsy medications and the extent to which the intervention
met its objectives of enhancing respondents' feelings of empowerment, support and control in
managing epilepsy.
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Service Costs
l Data on consultations with nurses and other staff.
l Record the number of days off work due to health problems and speciﬁcally epilepsy.
The evidence produced from this study will be useful to inform practice improvement/development in
deprived areas and has the potential to promote well being for people with epilepsy.
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Appendix 2 Epilepsy nurse specialist-led
self-management intervention checklist
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Appendix 3 Composite participant
questionnaire pack
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